Plant ID: NPO24447
Plant Latin Name: Thalictrum Cultratum
Taxonomy Genus: Thalictrum
Taxonomy Family: Ranunculaceae
NCBI TaxonomyDB:
341022
Plant-of-the-World-Online:
n.a.
India; China
Ingredient ID: NPC99068
Ingredient ID: NPC85561
Ingredient ID: NPC7973
Ingredient ID: NPC78302
Ingredient ID: NPC75844
Ingredient ID: NPC7466
Ingredient ID: NPC74580
Ingredient ID: NPC70036
Ingredient ID: NPC67195
Ingredient ID: NPC65435
Ingredient ID: NPC55900
Ingredient ID: NPC49448
Ingredient ID: NPC478975
Ingredient ID: NPC478974
Ingredient ID: NPC478973
Ingredient ID: NPC478972
Ingredient ID: NPC478971
Ingredient ID: NPC478970
Ingredient ID: NPC478969
Ingredient ID: NPC478968
Ingredient ID: NPC478967
Ingredient ID: NPC478966
Ingredient ID: NPC478965
Ingredient ID: NPC478964
Ingredient ID: NPC478963
Ingredient ID: NPC4481
Ingredient ID: NPC43412
Ingredient ID: NPC312617
Ingredient ID: NPC310934
Ingredient ID: NPC302275
Ingredient ID: NPC299565
Ingredient ID: NPC29841
Ingredient ID: NPC293539
Ingredient ID: NPC292902
Ingredient ID: NPC288669
Ingredient ID: NPC287979
Ingredient ID: NPC287865
Ingredient ID: NPC286342
Ingredient ID: NPC286170
Ingredient ID: NPC281131
Ingredient ID: NPC266960
Ingredient ID: NPC26596
Ingredient ID: NPC26496
Ingredient ID: NPC262756
Ingredient ID: NPC25495
Ingredient ID: NPC253634
Ingredient ID: NPC238192
Ingredient ID: NPC235215
Ingredient ID: NPC22472
Ingredient ID: NPC22449
Ingredient ID: NPC222750
Ingredient ID: NPC221388
Ingredient ID: NPC219737
Ingredient ID: NPC214138
Ingredient ID: NPC209846
Ingredient ID: NPC208683
Ingredient ID: NPC20791
Ingredient ID: NPC207691
Ingredient ID: NPC204854
Ingredient ID: NPC203050
Ingredient ID: NPC197499
Ingredient ID: NPC19687
Ingredient ID: NPC195046
Ingredient ID: NPC191459
Ingredient ID: NPC190322
Ingredient ID: NPC189958
Ingredient ID: NPC185170
Ingredient ID: NPC176665
Ingredient ID: NPC169959
Ingredient ID: NPC166778
Ingredient ID: NPC163524
Ingredient ID: NPC142771
Ingredient ID: NPC137915
Ingredient ID: NPC130894
Ingredient ID: NPC129909
Ingredient ID: NPC123557
Ingredient ID: NPC117418
Ingredient ID: NPC117383
Ingredient ID: NPC1157
Ingredient ID: NPC115245
Ingredient ID: NPC114132
Ingredient ID: NPC112248
Ingredient ID: NPC10980
Ingredient ID: NPC105574
Ingredient ID: NPC105242
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A1 | Cytochrome P450 1A1 | P04798 | CHEMBL2231 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 | Cytochrome P450 family 1 | CYP1B1 | Cytochrome P450 1B1 | Q16678 | CHEMBL4878 |
Therapeutic Target | Enzyme | NOX4 | NADPH oxidase 4 | Q9NPH5 | CHEMBL1250375 |
Therapeutic Target | Enzyme | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Therapeutic Target | Enzyme | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Therapeutic Target | Isomerase | TOP1 | DNA topoisomerase I | P11387 | CHEMBL1781 |
Therapeutic Target | Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Therapeutic Target | Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Oxidoreductase | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Therapeutic Target | Oxidoreductase | HSD17B2 | Estradiol 17-beta-dehydrogenase 2 | P37059 | CHEMBL2789 |
Therapeutic Target | Peptide receptor (family A GPCR) | NPSR1 | Neuropeptide S receptor | Q6W5P4 | CHEMBL5162 |
Therapeutic Target | Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Therapeutic Target | Phosphodiesterase | TDP2 | Tyrosyl-DNA phosphodiesterase 2 | O95551 | CHEMBL2169736 |
Therapeutic Target | Phosphodiesterase | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Therapeutic Target | Protein Kinase | PIM1 | Serine/threonine-protein kinase PIM1 | P11309 | CHEMBL2147 |
Therapeutic Target | Protein Kinase | YES1 | Tyrosine-protein kinase YES | P07947 | CHEMBL2073 |
Therapeutic Target | Protein Kinase | AURKB | Serine/threonine-protein kinase Aurora-B | Q96GD4 | CHEMBL2185 |
Therapeutic Target | Protein Kinase | AXL | Tyrosine-protein kinase receptor UFO | P30530 | CHEMBL4895 |
Therapeutic Target | Protein Kinase | MTOR | Serine/threonine-protein kinase mTOR | P42345 | CHEMBL2842 |
Therapeutic Target | Protein Kinase | IGF1R | Insulin-like growth factor I receptor | P08069 | CHEMBL1957 |
Therapeutic Target | Protein Kinase | MET | Hepatocyte growth factor receptor | P08581 | CHEMBL3717 |
Therapeutic Target | Protein Kinase | KDR | Vascular endothelial growth factor receptor 2 | P35968 | CHEMBL279 |
Therapeutic Target | Protein Kinase | CHEK1 | Serine/threonine-protein kinase Chk1 | O14757 | CHEMBL4630 |
Therapeutic Target | Protein Kinase | FLT3 | Tyrosine-protein kinase receptor FLT3 | P36888 | CHEMBL1974 |
Therapeutic Target | Protein Kinase | CDK1 | Cyclin-dependent kinase 1 | P06493 | CHEMBL308 |
Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Therapeutic Target | Secreted protein | HBB | Hemoglobin beta chain | P68871 | CHEMBL4331 |
Therapeutic Target | Small molecule receptor (family A GPCR) | HTR2B | Serotonin 2b (5-HT2b) receptor | P41595 | CHEMBL1833 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Therapeutic Target | Transcription factor | AHR | Aryl hydrocarbon receptor | P35869 | CHEMBL3201 |
Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Therapeutic Target | Unclassified protein | PMP22 | Peripheral myelin protein 22 | Q01453 | CHEMBL1293298 |
Therapeutic Target | Unclassified protein | GMNN | Geminin | O75496 | CHEMBL1293278 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 1236 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT04937738 | Perioperative Chemotherapy in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00289445 | Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) | metastasis;neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02937116 | A Dose Escalation Study of MM-398 Plus Irinotecan in Patients With Unresectable Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT04495088 | Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00020787 | Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003018 | S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02225652 | A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01896531 | A Study of Ipatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00004089 | Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02319304 | Pelvic Radiotherapy With Concurrent Neoadjuvant FOLFOX for Patients With Newly Diagnosed Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02827201 | FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01708278 | Beneficial Effects of Quercetin in Chronic Obstructive Pulmonary Disease (COPD) | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT00309478 | Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00176774 | Irinotecan, 5-Fluorouracil, and Leucovorin in Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00983541 | Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma | cancer | Fluorouracil (NPC75844) | NP level |
NCT00710736 | A Study of ARRY-334543 and Capecitabine in Patients With Advanced Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00625898 | BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00527111 | Pre-op Rectal ChemoRad +/- Cetuximab | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05235542 | A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT03358472 | Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01836432 | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04149015 | Neoadjuvant POF in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05476432 | HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003577 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01843049 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00004206 | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT00024427 | Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04217954 | HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT03323463 | Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma | oropharynx squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02590133 | A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05276895 | Effect of Natural Senolytic Agents & NLRP3 Inhibitors on Osteoarthritis | osteoarthritis | Quercetin (NPC20791) | NP level |
NCT02465593 | A Study of PEP503(Radio-enhancer) With Radiotherapy and Chemotherapy for Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00551759 | Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT05462496 | Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04649476 | Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00331097 | ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04393298 | A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00429299 | Neoadjuvant Study With Chemotherapy, Lapatinib And Trastuzumab In Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05314998 | Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05024513 | Biliary Drainage Plus HAIC in Locally Advanced pCCA | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03899636 | A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00608205 | Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01031030 | Cyclophosphamide, Methotrexate, and Fluorouracil, With or Without Epirubicin Hydrochloride, in Treating Women Who Have Undergone Surgery for Breast Cancer (Group III Closed to New Patients as of 12/7/2009) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003549 | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT05052099 | Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00049348 | Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00797485 | Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00556413 | Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03043729 | mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00660270 | Chemotherapy and Radiation Following Pancreatic Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05350943 | HAIC Combined With Toripalimab and Donafenib for Advanced BTC | biliary tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00513383 | Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04488159 | Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004931 | Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03641976 | A Study of Bevacizumab, Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (A-FOLFOXIRI) Compared With Bevacizumab, Infusional Fluorouracil, Leucovorin, and Irinotecan/Oxaliplatin (A-FOLFIRI/FOLFOX) as First-line Treatment for Metastatic Right-sided Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01479465 | Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00016952 | Irinotecan or Fluorouracil Plus Leucovorin in Treating Patients With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01183780 | A Study in Second Line Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00145769 | A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00215501 | Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00000122 | Fluorouracil Filtering Surgery Study (FFSS) | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00811993 | A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02720068 | Study of Favezelimab (MK-4280) as Monotherapy and in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy or Lenvatinib (MK-7902) AND Favezelimab/Pembrolizumab (MK-4280A) as Monotherapy in Adults With Advanced Solid Tumors (MK-4280-001) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03574324 | TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01593020 | Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00027833 | Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03299660 | Avelumab With Chemoradiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00599131 | Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) | laryngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00262808 | GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003835 | Combination Chemotherapy in Treating Patients With Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04241185 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | bladder tumor | Fluorouracil (NPC75844) | NP level |
NCT04005339 | NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00002689 | Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05253651 | A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02241551 | Phase II Neoadjuvant Chemotheraphy (Gemcitabine and Nab-Paclitaxel vs. mFOLFIRINOX) and Sterotatic Body Radiation Therapy for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00343239 | Docetaxel in Locally Advanced Gastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04393584 | FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00921531 | Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03109158 | NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05062889 | Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03837977 | Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003298 | Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00720512 | Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00508664 | Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA) | hypopharyngeal carcinoma;laryngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03764553 | Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00324415 | Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01358877 | A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00275119 | Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02590367 | Estimate the Efficacy of HD6610 Granule for Oxaliplatin-induced Peripheral Neuropathy | peripheral neuropathy | Fluorouracil (NPC75844) | NP level |
NCT00268333 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01542931 | TPF Induction Chemotherapy for Locally Advanced and Resectable Oral Squamous Cell Carcinoma | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01472016 | Study of ABT-700 in Subjects With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03693677 | First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRI | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00202969 | Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00020488 | Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01041404 | ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02539537 | A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003558 | Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00202787 | Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01333709 | Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03189719 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590) | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00069121 | A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02545504 | Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00025090 | Radiation Therapy Plus Fluorouracil With or Without Additional Chemotherapy in Treating Patients With Primary Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01528618 | Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002755 | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003596 | Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00112918 | Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03161574 | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01211210 | Neoadjuvant FOLFOX6 Chemotherapy With or Without Radiation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03736720 | Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin | pancreatic endocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03855384 | Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck(R/M SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00098787 | Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003576 | Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00352755 | A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal Carcinomatosis | peritoneal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02510118 | Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00005979 | Combination Chemotherapy With or Without Irinotecan in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02041481 | MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00001428 | A Phase II Study of 5-Fluorouracil Administered as a One Hour Infusion in Combination With Calcium Leucovorin and Interferon Alpha-2A in Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04821284 | Sonoporation and Chemotherapy for the Treatment of Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00009737 | A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00499369 | Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03386838 | An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00215514 | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01217060 | Trimodality Management of T1b Esophageal Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03941093 | Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04185883 | Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00422864 | A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01481545 | Bevacizumab With Pelvic Radiotherapy And Primary Chemotherapy in Patients With Poor-Risk Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05201430 | Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01205711 | Irinotecan Hydrochloride, Fluorouracil, and Leucovorin Calcium With or Without Zibotentan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00033683 | Combination Chemotherapy in Treating Women With Resected Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05033522 | Immunotherapy for Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002542 | Tamoxifen in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02588105 | Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01206465 | Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00284258 | Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03175666 | QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00230451 | Pre-operative Chemotherapy and Radiation Therapy for Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01779050 | Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05125055 | Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC | oral squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00142350 | A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003642 | Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT01802645 | Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01930552 | A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01851941 | A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01332604 | GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT04733534 | An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer | childhood cancer | Quercetin (NPC20791) | NP level |
NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05268510 | Chemotherapy and Pembrolizumab, Followed by Pembrolizumab and Olaparib as Firstline Therapy in Her-2 Negative Gastric/GEJ Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04423965 | A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00950300 | A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01081041 | A Study in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04358354 | Triplet Combination of Cytotoxics as First-line Treatment for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00003216 | Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03675737 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859) | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00110721 | GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04541108 | Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04004871 | Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01245959 | Induction Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00321828 | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colon Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02980965 | Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03722498 | Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00807911 | Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00258323 | Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04151277 | PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05422885 | Safety and Feasibility of Dasatinib and Quercetin in Adults at Risk for Alzheimer's Disease | aging | Quercetin (NPC20791) | NP level |
NCT02826837 | LEAC-102 for Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00749450 | Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01494363 | Phase II Study of FOLFOXIRI in Patients With Locally Advanced or Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00003862 | Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01662869 | A Study of Onartuzumab in Combination With mFOLFOX6 in Participants With Metastatic HER2-Negative and MET-Positive Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00070434 | S0304 Induct Chemo Then Chemo-RT in Pts w/Locally Advanced Adenocarcinoma of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00155883 | Bi-Weekly Docetaxel Plus 24-Hour Infusion of High-Dose 5-Fluorouracil / Leucovorin (HDFL) for Inoperable Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00075595 | Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00677118 | Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01198548 | High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01348217 | Radiochemotherapy With and Without Dose Escalation in Patients Presenting Locally Advanced or Inoperable Carcinoma of the Oesophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00064181 | Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00209703 | Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02508077 | FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004003 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00052910 | Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00058201 | Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03825861 | Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01099358 | Study in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00337389 | Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00953394 | 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00237900 | Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01181401 | InductionChemo-Radio-Antibody-Treatment | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00478946 | A Study of Picoplatin in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03085992 | Folfoxiri Plus Bevacizumab Followed by Chemoradiotherapy Plus Bevacizumab in Patients With Resectable Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00004005 | Irinotecan Followed By Fluorouracil and Leucovorin in Treating Patients With Stage III or Stage IV Colorectal Carcinoma (Cancer), Other Refractory Carcinoma, or Metastatic Adenoma (Cancer) of Unknown Primary Origin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03577704 | The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002716 | Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03921684 | Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01985841 | Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01489566 | Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02000050 | Phase II Study of Up-front Chemotherapy and Neo-adjuvant Short-course Radiotherapy for Resectable Rectal Carcinoma (COLORE) | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05029973 | HAIC Combined With Sintilimab and Bevacizumab Biosimilar for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02534337 | Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01608464 | Pre-op Chemo-RT w/CDDP/5FU vs Chemo w/ Docetaxel/Irinotecan in PET Non Responder Resectable Esophagus Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00003446 | Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03050814 | Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05456022 | Therapeutic Efficacy of Quercetin Versus Its Encapsulated Nanoparticle on Tongue Squamous Cell Carcinoma Cell Line | mouth neoplasm | Quercetin (NPC20791) | NP level |
NCT00268372 | S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00533936 | Trastuzumab or Observation After Combination Chemotherapy and Trastuzumab in Treating Patients Undergoing Surgery for Stage II or Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03783442 | A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01276379 | Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03800693 | 2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT01893294 | Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00816816 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00507585 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT04757363 | A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01858025 | Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00052429 | High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01413022 | FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02830139 | Radical Colorectal Resection and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00004099 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02172976 | Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03250832 | Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05433597 | A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT00021398 | Radiation Therapy and Chemotherapy Followed by Surgery and Combination Chemotherapy in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02023593 | FOLFIRI as Second Line Chemotherapy for Metastatic Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00044785 | Phase I Study of PN401, Fluorouracil, Leucovorin and CPT-11 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00525759 | Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03524508 | Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00861094 | Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02514278 | Optimisation of Response for Organ Preservation in Rectal Cancer : Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01529164 | Efficacy and Safety Study of Recombinant Endostatin Combined With Chemotherapy to Treat Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003994 | Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00402545 | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05319639 | Phase I Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02563054 | A Study of Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00021320 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00379262 | Therapeutic Gain by Induction-concurrent Chemoradiotherapy and/or Accelerated Fractionation for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01286766 | Neoadjuvant Combination Chemotherapy of DCS (Cisplatin + Docetaxel + S-1) and DCF (Docetaxel + Cisplatin + 5-FU) in Patients With Locally Advanced Gastric Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04437329 | Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00640081 | Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02358031 | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02353260 | Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02352337 | First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00646659 | Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00202774 | Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01197664 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02741570 | Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03443661 | Neoadjuvant Triplet Chemotherapy Regimen in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00647530 | Fluorouracil and Oxaliplatin With or Without Panitumumab In Treating Patients With High-Risk Colon Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00378716 | Combination Chemotherapy in Treating Patients With Resected Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00941655 | Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03861702 | Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01285557 | Diffuse Gastric and Esophagogastric Junction Cancer S-1 Trial | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02506842 | Second-Line Adjuvant Therapy With Nab-Paclitaxel Plus Gemcitabine Versus Oxaliplatin Plus Folinic Acid and Fluorouracil for Gemcitabine-Refractory Pancreatic Cancer After Curative Resection | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003637 | Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002524 | Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma | Lymphoma, AIDS-Related | Fluorouracil (NPC75844) | NP level |
NCT01871571 | Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01500993 | Capecitabine in the Perioperative Treatment of Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01536223 | Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03699319 | CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01787006 | Definitive Radiochemotherapy Plus/Minus Cetuximab in Unresectable Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01383707 | A Study of Bevacizumab and Modified FOLFOX-6 (mFOLFOX-6) in Participants With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006366 | Radiation Therapy Plus Chemotherapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01862003 | Phase I/II Trial of Antagonism of HER in GI Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00021073 | Combination Chemotherapy in Treating Patients With Advanced Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004150 | High-Dose Fluorouracil With or Without Leucovorin Compared With Standard Fluorouracil Plus Leucovorin Following Surgery in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00046995 | Combination Chemotherapy in Treating Patients With Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00711243 | Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00551213 | A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02069041 | A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00321685 | Bevacizumab, Radiation Therapy, and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Nonmetastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03000374 | Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04481204 | New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04962958 | Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02405585 | Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00008060 | Combination Chemotherapy in Treating Patients With Unresectable Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05179889 | Adjuvant FOLFOXIRI for High-risk Stage III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00026273 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients Following Surgery for Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00384878 | Study of Cetuximab Plus P-HDFL for the First-Line Treatment of Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05469061 | Tislelizumab in Combination With Chemotherapy for Conversion Therapy of Locally Nonresectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01748851 | XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC) | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00992199 | Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Local Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002580 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03939962 | Camrelizumab Combined With FOLFOX Neoadjuvant Therapy for Resectable Gastric and Gastroesophageal Junctional Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002774 | Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00188877 | Intensity Modulated Radiation Therapy for Head and Neck Cancer | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03143153 | A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT03300609 | 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484299 | Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | esophageal carcinoma;stomach neoplasm;adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00500292 | A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT01661088 | A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00062426 | Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03604965 | GP Induction Chemotherapy us TPF Adjuvant Chemotherapy Combined With DDP Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00042874 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03167164 | QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy | Merkel cell skin cancer | Fluorouracil (NPC75844) | NP level |
NCT04176952 | PRIMUS002: Looking at 2 Neo-adjuvant Treatment Regimens for Resectable and Borderline Resectable Pancreatic Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03428529 | Capecitabine Versus Bolus 5-Fu Associated to Radiotherapy as Neoadjuvant Treatment for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00209690 | Phase I/II Study of TPF as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02025023 | Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study | meibomian cyst | Fluorouracil (NPC75844) | NP level |
NCT02450058 | Adjuvant FEC Versus EP in Breast Cancer (MIG5) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003888 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00039208 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03607656 | The Effect of Traditional Chinese Treatment Combined Adjuvant Chemotherapy in IIIb and IIIc Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00838370 | Pharmacogenomic and Pharmacokinetic Safety and Cost-saving Analysis in Patients Treated With Fluoropyrimidines | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00080951 | Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02012062 | Concurrent Nimotuzumab Versus Cisplatin With Radiotherapy for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00095875 | Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02715531 | A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02246127 | Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET) | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01718873 | Optimization of Bevacizumab Scheduling With Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04431258 | ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04834206 | Nedaplatin in Treatment for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02551991 | Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04228601 | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00152191 | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01269216 | A Study of Neoadjuvant Chemoradiotherapy With 5-FU/Leucovorin (FL) vs. TS-1/Irinotecan in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03563248 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00126256 | Trial Comparing Two Strategies of Chemotherapy for Metastatic Colorectal Cancer | colorectal carcinoma;metastasis | Fluorouracil (NPC75844) | NP level |
NCT01274962 | A Study on the Timing of FOLFOX for Patients With Operable, Node Positive Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01216111 | Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01775501 | Sorafenib + mFOLFOX for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00425152 | Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03812770 | Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03370406 | Intralesional 5-Fluorouracil (5FU), Topical Imiquimod Treatment for SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00592501 | Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00042861 | UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03169764 | QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00209716 | Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04769414 | Flouro-Gem in Adenocarcinoma of the Pancreas (GEFLUPAN) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00096278 | Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01438320 | Q-Trial in Patients With Hepatitis C | chronic hepatitis C virus infection | Quercetin (NPC20791) | NP level |
NCT00003893 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03554109 | QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01774786 | A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00952029 | Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01566435 | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00149201 | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02059499 | Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions | anal neoplasm;squamous cell intraepithelial neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002722 | High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04420884 | A Study of TAK-676 as Single Agent and TAK-676 in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01720147 | Quercetin in Children With Fanconi Anemia; a Pilot Study | Fanconi anemia | Quercetin (NPC20791) | NP level |
NCT00005870 | Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01418222 | FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01867892 | A Phase II Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01312350 | Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN) | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01347645 | Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03548961 | Organ Preservation in Early Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00580073 | Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03504423 | Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05358704 | Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00416858 | Radiation Therapy and Combination Chemotherapy With or Without Surgery in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed By Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01326000 | A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00813137 | FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03136406 | QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00246103 | Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00509964 | Second-Line Irinotecan vs. ILF for AGC | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04927780 | Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03503604 | A Study of Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00460265 | Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00336960 | Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01591733 | FOLFIRINOX + RT for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00377273 | An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00577109 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01233843 | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01676259 | A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02897700 | A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00735345 | Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01622543 | Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03048123 | HAIC Versus TACE for Large and Unresectable Hepatocellular Carcinoma Staged BCLC A/B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00541125 | G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002582 | Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002496 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01183663 | Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) | cancer | Fluorouracil (NPC75844) | NP level |
NCT01465451 | Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02967289 | IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01154920 | Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02217020 | Neoadjuvant FOLFOXIRI Chemotherapy Alone for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01888978 | Molecularly Tailored Therapy for Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01855828 | Phase 2 Trial of Pertuzumab and Trastuzumab With Weekly Paclitaxel and Chemotherapy for HER2 Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002888 | Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00884767 | Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00449137 | Arsenic Trioxide, Fluorouracil, and Leucovorin in Treating Patients With Stage IV Colorectal Cancer That Has Relapsed or Not Responded to Treatment | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01375101 | Therapeutic Effect of Quercetin and the Current Treatment of Erosive and Atrophic Oral Lichen Planus | oral lichen planus | Quercetin (NPC20791) | NP level |
NCT00571740 | Cetuximab and Bevacizumab as First-Line Therapy Followed By Combination Chemotherapy and Bevacizumab With or Without Cetuximab as Second-Line Therapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01362374 | Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00479583 | Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX | cancer | Fluorouracil (NPC75844) | NP level |
NCT00544011 | Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05378919 | Neoadjuvant Therapy vs Standard Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00374036 | Metastatic Gastric Cancer FFCD 03-07 | gastric cancer;metastasis | Fluorouracil (NPC75844) | NP level |
NCT01417494 | 1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00929591 | SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00081289 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy in Treating Patients Who Are Undergoing Surgical Resection for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03013218 | A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01) | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00747799 | Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00967616 | Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053911 | Combination Chemotherapy Compared With Observation After Surgery in Treating Women With Relapsed Nonmetastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04946383 | Safety and Effectivness of Quercetin & Dasatinib on Epigenetic Aging | aging | Quercetin (NPC20791) | NP level |
NCT00003086 | Repeated Bone Marrow Transplantation in Treating Women With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00417209 | Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00502567 | A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00954512 | Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04215731 | Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01494506 | Study of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002615 | Surgery With or Without Combination Chemotherapy in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00111761 | Evaluating Panitumumab (ABX-EGF) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004897 | Combination Chemotherapy and Interferon Alfa Followed by Surgery and/or Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT05332002 | A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies | cancer | Fluorouracil (NPC75844) | NP level |
NCT00085163 | Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05446467 | Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01804790 | Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00611858 | Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04155671 | POF Versus FOLFOX Plus IP Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04722133 | Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00613080 | Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01827553 | Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00976768 | Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00002893 | Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01653470 | Study to Evaluate Safety & Tolerability of BMS-906024 in Combination With Chemotherapy & to Define DLTs & MTD of BMS-906024 in Combination With One of the Following Chemotherapy Regimens | cancer | Fluorouracil (NPC75844) | NP level |
NCT00999700 | Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03883919 | Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01279681 | Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00447967 | Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00941499 | Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab | cancer | Fluorouracil (NPC75844) | NP level |
NCT02178709 | A Phase II Study of Neoadjuvant FOLFIRINOX | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01013805 | Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00015886 | Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01283204 | Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00942266 | Vorinostat, Fluorouracil, and Leucovorin Calcium in Treating Patients With Metastatic Colorectal Cancer That Has Not Responded to Previous Treatment | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00055679 | Combination Chemotherapy in Treating Women With Stage I Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00070213 | Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01121848 | Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00570531 | Phase II Trial for Patients With Loco-Regional Esophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02021422 | A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT02485548 | Cisplatin Plus Raltitrexed or 5-fluorouracil Concurrent With Radiotherapy for Head and Neck Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03586869 | QUILT-3.080: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01126216 | Reduced Radiotherapy With Pac/Cis vs Standard Radiotherapy With 5-FU/Cis in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03197571 | QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | urothelial carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01220128 | Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00454116 | A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00023868 | Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02515734 | A Study of FOLFOXIRI Plus Cetuximab vs. FOLFOXIRI Plus Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03977233 | Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04807972 | Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer Metastasis | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559845 | A Study of Avastin (Bevacizumab) in Patients With Inflammatory or Locally Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003680 | Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00839111 | Sorafenib and FOLFIRI Regimen in 2nd Colorectal Cancer (CRC) After Failure of Oxaliplatin Treatment | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00005068 | Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002839 | Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04749108 | Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04161755 | Study of Personalized Tumor Vaccines (PCVs) and a PD-L1 Blocker in Patients With Pancreatic Cancer That Can be Treated With Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002897 | Surgery With or Without Chemotherapy in Treating Patients With Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01524094 | Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04672005 | Modified FOLFIRINOX Alternated With Biweekly Gemcitabine Plus Nab-Paclitaxel Untreated Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05132504 | Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00296608 | Radiation Therapy With or Without Chemotherapy Before Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01632306 | A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01171482 | Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01821729 | Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01911598 | A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT00417976 | Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03164382 | Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00425425 | Cetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01227707 | A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005871 | Nitrocamptothecin or Fluorouracil in Treating Patients With Recurrent or Refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004865 | Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00357149 | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS) | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03291899 | Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00024349 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00069095 | A Study of Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01063192 | A Study of Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04832776 | FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04838496 | Induction Chemotherapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02494583 | Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387098 | QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01327521 | Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00121992 | Docetaxel, Doxorubicin (A), Cyclophosphamide (C) (TAC) vs 5-Fluorouracil, A, C (5FAC) Breast Cancer Adjuvant Treatment | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01652976 | Phase II Study of 5-FU, Oxaliplatin Plus Dasatinib in Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01498783 | Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma | central nervous system cancer;ependymoma | Fluorouracil (NPC75844) | NP level |
NCT04793932 | Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT05221658 | A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07 Combination Therapy or Monotherapy in Patients With Advanced ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00089024 | Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00117572 | Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) | laryngeal neoplasm;oral cavity cancer;paranasal sinus neoplasm;pharynx cancer | Fluorouracil (NPC75844) | NP level |
NCT00087178 | Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02723955 | Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01642771 | Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03541252 | Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study | basal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003652 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02581215 | Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04259944 | Post-surgical Liquid Biopsy-guided Treatment of Stage III and High-risk Stage II Colon Cancer Patients: the PEGASUS Trial | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01650428 | Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00868491 | Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00003175 | Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT03281369 | A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer) | esophageal carcinoma;gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01522989 | PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor Malignancies | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00609622 | Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01590719 | A Study of Onartuzumab (MetMAb) in Combination With mFOLFOX6 in Patients With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2) Negative Gastroesophageal Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02167321 | Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03085914 | A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04418895 | Neoadjuvant Therapy for Localized Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00016198 | Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04675983 | A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006015 | Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03469479 | Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03082209 | First in Human Study of IBI308 in Chinese Subjects With Advanced Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT00005791 | Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00602602 | Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00548548 | A Study of Bevacizumab in Combination With Capecitabine and Cisplatin as First-line Therapy in Patients With Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02710734 | Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN) | urinary bladder carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02742051 | A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01177956 | A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002999 | S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04379596 | Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2+ Gastric Cancer (DESTINY-Gastric03) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00238160 | Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT05239741 | Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01314833 | Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03015675 | IV Ascorbic Acid in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01374425 | Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03989271 | Biological Effects of Quercetin in COPD | chronic obstructive pulmonary disease | Quercetin (NPC20791) | NP level |
NCT04703101 | Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004059 | Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00311636 | Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002579 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00183911 | Study of 5-Fluorouracil and Leucovorin and Intra-abdominal Floxuridine Chemoradiation in Patients With Fully Resected Locally Advanced Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05081687 | Brazilian Total Neoadjuvant Therapy Trial | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05214339 | A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepatocellular Carcinoma in BCLC Classification (D-TRIPLET) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03671252 | Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00265811 | Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00209625 | Phase I / II Study of Irinotecan (CPT-11) Combined With l-Leucovorin (l-LV) and 5-FU in Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04460352 | Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387111 | QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002747 | Surgery and Radiation Therapy With or Without Chemotherapy in Treating Patients With Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03017326 | Paediatric Hepatic International Tumour Trial | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT04550260 | Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01167725 | Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00280176 | Bortezomib, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05251038 | Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00203905 | A Study of Chemoradiotherapy for Intermediate Stage/Selected Stage IV Cancers of the Head and Neck | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT05263219 | DEB-TACE+HAIC vs. HAIC for Large HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05078827 | Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With Fluorouracil 5% Topical Cream of MylanPharmaceuticals Inc., U.S.A in the Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT04607421 | A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04621370 | A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04990037 | A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00274937 | Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05062486 | A Study to Evaluate the Safety and Efficacy of RQC for AMD | age-related macular degeneration | Quercetin (NPC20791) | NP level |
NCT04539808 | NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01372202 | CHFR Methylation Status Esophageal Cancer Study | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03168607 | Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387592 | CAPTEM or FOLFIRI as SEcond-line Therapy in NEuroendocrine CArcinomas | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02848131 | Senescence in Chronic Kidney Disease | chronic kidney disease | Quercetin (NPC20791) | NP level |
NCT02008656 | Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04229459 | Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01036087 | Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | esophageal carcinoma;stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01226719 | FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00537823 | Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00093665 | Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02244632 | Modufolin (Arfolitixorin) in Combination With 5-Fluorouracil Alone or Together With Oxaliplatin or Irinotecan in Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002870 | High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Locally Recurrent or Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03806309 | Maintenance With OSE2101 Plus FOLFIRI, or FOLFIRI After FOLFIRINOX-based Induction Therapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01839344 | Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes. | type 2 diabetes mellitus | Quercetin (NPC20791) | NP level |
NCT00889343 | Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004913 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05472259 | A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04120701 | CIRCULATING TUMOR DNA BASED DECISION FOR ADJUVANT TREATMENT IN COLON CANCER STAGE II | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04755543 | A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02017600 | A Phase II Trial of Induction Chemotherapy With ND-420, Cisplatin and Fluorouracil Followed by Surgery in the Treatment of Patients With Localized Squamous Cell Carcinoma of the Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02291289 | A Study of Biomarker-Driven Therapy in Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003777 | Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01523457 | Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02296671 | Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03110510 | FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT01047007 | A Dose Escalation Study of MK1775 in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005) | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01554059 | Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05466799 | FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03748134 | Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01836653 | Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05253846 | Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01912820 | Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | prostate adenocarcinoma | Quercetin (NPC20791) | NP level |
NCT00003331 | Combination Chemotherapy in Treating Patients With Advanced Cancer | chronic myeloproliferative disorder;multiple myeloma;myelodysplastic syndrome | Fluorouracil (NPC75844) | NP level |
NCT02959879 | Neo-adjuvant FOLF(IRIN)OX for Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03387085 | QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00544414 | Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00098982 | Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01046864 | Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) | cancer | Fluorouracil (NPC75844) | NP level |
NCT03991962 | Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03259035 | NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04428333 | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | head and neck neoplasia | Fluorouracil (NPC75844) | NP level |
NCT04130854 | INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00385021 | ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02842580 | De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01525329 | Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00041262 | Combination Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02289768 | Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00278889 | Second Line ColoRectal Cancer Therapy in Combination With Combination of FOL- Folinic Acid(Leucovorin), F - Fluorouracil and OX - Oxaliplatin (FOLFOX) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04047862 | Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03279237 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01271166 | Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT00427310 | Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002884 | Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03092895 | A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC | carcinoma;liver cancer | Fluorouracil (NPC75844) | NP level |
NCT02393833 | IBCSG Trial 22-00 Serum Substudy | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04994236 | Hepatic Artery Infusion Chemotherapy for Unresectable Hepatocelluar Carcinoma Who Failed to Systemic Therapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03336216 | A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00001579 | A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT04358341 | Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03503136 | Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02384850 | Phase 1 Trial To Evaluate mFOLFOX6 With Selinexor In Patients With Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03959293 | Clinical Trial Evaluating FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab and Tremelimumab in Second-line Treatment of Patients With Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01740648 | Trametinib, Fluorouracil, and Radiation Therapy Before Surgery in Treating Patients With Stage II-III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002883 | Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00733889 | A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01434069 | Phase I Trial of Combination of FOLFIRI and SOM 230 | digestive system neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003078 | Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT00501410 | FOLFOX Chemotherapy Regimen (5-FU, Leucovorin, Oxaliplatin) in Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03169790 | QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL | non-Hodgkins lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00188266 | Study of Adjuvant Radiochemotherapy for Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00113399 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01572324 | Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00083109 | Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer | renal cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02640365 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00980460 | Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT00251355 | Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00671372 | A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02897050 | Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00002896 | Radiation Therapy Plus Chemotherapy Before Surgery With or Without Chemotherapy After Surgery in Treating Patients With Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00601627 | Panitumumab, Chemotherapy, and External-Beam Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot be Removed by Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00786643 | Study of Gamma Interfereon in Metastatic Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01375816 | Liposome-encapsulated Irinotecan Hydrochloride PEP02 or Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil as Second-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03167177 | QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy | melanoma | Fluorouracil (NPC75844) | NP level |
NCT00335816 | Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00628810 | Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04089150 | MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00497497 | A Study of PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00915850 | Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC) | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02138617 | Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003012 | Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04337879 | A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT02704520 | Magnetic Resonance Tumour Regression Grade as Biomarker for Stratified Management of Rectal Cancer Patients | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02440958 | Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00811447 | Taxotere New Indication - Gastric Cancer Treatment Registration Trial | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03127007 | Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00688740 | Docetaxel in Node Positive Adjuvant Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00077233 | FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00208936 | Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT00021281 | Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00020501 | Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01289821 | First Line Treatment of Metastatic Colorectal Cancer With mFOLFOX6 in Combination With Regorafenib | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00261703 | Docetaxel in Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003260 | Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00174707 | Study of Docetaxel in Breast Cancer Patients | breast neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03197584 | QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy | ovarian cancer | Fluorouracil (NPC75844) | NP level |
NCT04478292 | A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy | Hepatoblastoma | Fluorouracil (NPC75844) | NP level |
NCT05024097 | A Phase II Study to Test the Efficacy of AB928 (Dual Adenosine Receptor Antagonist) and AB122 (a PD1 Checkpoint Inhibitor) in Combination With Short Course Radiotherapy and Consolidation Chemotherapy for Rectal Cancer. | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00016133 | Vaccine Therapy in Treating Patients With Stage II or Stage III Colon Cancer That Has Been Removed During Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00012311 | Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04370418 | A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab | cancer | Fluorouracil (NPC75844) | NP level |
NCT00002692 | Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01277406 | 4SC-201 (Resminostat) in Advanced Colorectal Carcinoma | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03781323 | Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02459457 | A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02500940 | Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00431080 | Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05257993 | Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00262951 | Chemoradiation in Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01605344 | Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01736904 | wXELIRI Versus FOLFIRI Regimen in the Treatment of Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00755118 | Lohp, 5-Fu/Lv and Bevacizumab, Alternative With Cpt-11, 5-Fu/Lv and Cetuximab In Metastatic Crc | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05171166 | Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02028806 | mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03760614 | A Study of Entinostat and FOLFOX in Subjects With Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00427570 | Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02468557 | Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00023660 | Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer | cervical cancer | Fluorouracil (NPC75844) | NP level |
NCT00068744 | Radiation Therapy, Mitomycin, and Either Fluorouracil or Cisplatin in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT04068103 | Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02452853 | HR Combined With FOLFOX4 for HCC With PVTT | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01047293 | RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004901 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00958737 | Combination Chemotherapy for 3 Months or 6 Months in Treating Patients With Stage III Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02359968 | PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02817113 | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00831181 | Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003049 | Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006037 | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02434614 | Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00033735 | Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04324307 | Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02270606 | Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04292743 | Eryaspase With Modified FOLFIRINOX in Advanced Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003799 | Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01150045 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003287 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01338558 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03574649 | QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05047991 | Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004885 | Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00721513 | Docetaxel, Cisplatin, and Fluorouracil Followed By Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02114359 | Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04127019 | Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00940303 | OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00212589 | Patients Preference for Oral or i.v. Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04949256 | Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014) | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00629278 | Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03869034 | HAIC Combined With PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00352118 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03780634 | HAIC Plus PD-1 Antibody vs HAIC Plus Sorafenib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02688712 | ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT02676349 | Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03970252 | Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01142414 | Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients Who Have Undergone Surgery for Advanced Hypopharyngeal Cancer, Oropharyngeal Cancer, Laryngeal Cancer, or Oral Cavity Cancer at High Risk of Recurrence | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02375672 | Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002523 | Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00005060 | Combination Chemotherapy and Surgery in Treating Patients With Locally Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00123318 | A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00436267 | Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01627379 | Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04354662 | Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02016417 | Induction Chemotherapy With GP Versus TPF in the Treatment of Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00381706 | Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04084496 | mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04907253 | Quercetin in Coronary Artery By-pass Surgery | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT00832299 | Neo-Adjuvant FOLFOX for Rectal Carcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002793 | Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00423696 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04523818 | Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04926753 | Induction Chemotherapy Combined With Toripalimab in Locoregionally-Advanced Laryngo-Hypopharyngeal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03487939 | Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01621217 | Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0 | anal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02048540 | Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | lymphoma | Fluorouracil (NPC75844) | NP level |
NCT00054054 | S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01591135 | A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003422 | Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002735 | SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00052559 | Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003627 | Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Advanced Cancer of the Oropharynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00308516 | 5-Fluorouracil, Bevacizumab, and Radiation Followed by Modified FOLFOX6 and Bevacizumab in Stage II/III Rectal Cancer | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01231802 | Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02423226 | Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05348811 | HAIC Combined With Donafenib and Sintilimab for Unresectable ICC | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00778102 | A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00023751 | Surgery With or Without Chemotherapy and Radiation Therapy in TreatingPatients With Stage I Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00022178 | Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin | carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00448136 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00610948 | Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03391843 | Neoadjuvant Chemotherapy Combined With Cetuximab for EGFR Wild Type Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00080990 | Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00193882 | Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02351219 | FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04839731 | Combination 5-FU / Calcipotriene Cream for SCCIS/SCC | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01889303 | Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01263171 | Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03563144 | QUILT-3.088: NANT Pancreatic Cancer Vaccine | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01716949 | Neoadjuvant Chemoradiation With 5-FU(or Capecitabine) and Oxaliplatin Combined With Hyperthermia in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04009876 | A Study to Evaluate a Chemotherapy Treatment Followed by Chemo and Radiotherapy in Patients With Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002476 | Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00008281 | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02820857 | Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01442649 | Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03606928 | mFLOT Chemotherapy as First-line Treatment in GC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00467142 | Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01485744 | LDE225 With Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan for Untreated Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03778593 | FOLFIRINOX for 2nd-line Treatment of BTC | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT05174169 | Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01750918 | Weekly Paclitaxel, 5FU+Irinotecan or Carboplatin+Paclitaxel in Subjects With Advanced / Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT05412082 | SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01478594 | A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04897854 | Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00416507 | Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03169738 | QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | non-small cell lung carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01238965 | Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03368859 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | cancer | Fluorouracil (NPC75844) | NP level |
NCT03300544 | Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01704690 | Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT03192644 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00816855 | Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01127555 | Salvage mFOLFOX in BTC After Failure of Gemcitabine | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00303628 | Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00003013 | Chemotherapy Plus Surgery in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02941562 | A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00020917 | Cetuximab Plus Combination Chemotherapy in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03780049 | HAIC Plus H101 vs HAIC Alone for Unresectable HCC at BCLC A-B | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01454180 | Study of Individualized Selection of Chemotherapy in Patients With Advanced Pancreatic Carcinoma According to Therapeutic Targets | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02218164 | Capecitabine or 5-FU With Pegylated Interferon Alpha-2b in Unresectable/Metastatic Cutaneous Squamous Cell Carcinoma | skin carcinoma;squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00220649 | Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00003063 | Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02426450 | RFA Combined With Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) for Recurrent HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04997837 | Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00139269 | Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04170530 | Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00756470 | Phase II Neoadjuvant in Inflammatory Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04380337 | Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00054587 | Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04303429 | Adjuvant Chemotherapy in High Risk Stage II Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03329248 | QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01348204 | Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators | cystic fibrosis | Quercetin (NPC20791) | NP level |
NCT03879109 | Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00707889 | Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer | colorectal adenocarcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04752696 | Onvansertib in Combination With Nanoliposomal Irinotecan, Leucovorin, and Fluorouracil for Second-Line Treatment of Participants With Metastatic Pancreatic Ductal Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309530 | Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01488552 | Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002498 | Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01688336 | FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00026364 | ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003001 | Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02934464 | Assessment of Ramucirumab Plus Paclitaxel as Switch MANteInance Versus Continuation of First-line Chemotherapy in Patients With Advanced HER-2 Negative Gastric or Gastroesophageal Junction Cancers | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03603834 | Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00025142 | Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00307723 | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04919226 | Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE | neuroendocrine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02402842 | Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01446458 | Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01765582 | Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00268398 | Combination Chemotherapy in Treating Patients With Colorectal Cancer and Resectable Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05217069 | A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00609765 | Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02482441 | A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10 | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT05193292 | Camrelizumab Combined With Trastuzumab and Chemotherapy in Patients With HER2-positive Advanced Colorectal Cancer | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01679327 | Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00118261 | Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02717091 | Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00424827 | A Trial of Chemo & Radiation Therapy for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03694522 | A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03224221 | Apatinib Combined With Chemotherapy for Esophageal Squamous Cell Cancer After the Failure of Standard Treatment | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02071069 | Efficacy and Tolerance of Maintenance Therapy in Patients With Incurable Advanced Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03175939 | Elimination of Adjuvant Chemotherapy for Selected Stage II and III Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01354717 | Bioequivalence Study of Generic Fluorouracil 0.5% Cream and 0.5% Carac® and Placebo | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00721916 | Randomized Phase II Study of SOL for Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01836029 | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00274872 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01376453 | Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03037541 | Cryosurgery and Cream Combination for Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT00217737 | Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | Lynch syndrome;signet ring cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01383343 | Sorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03331640 | A Health Service Research Study to Investigate Survival of Metastatic Pancreatic Cancer Patients After Sequential Chemotherapy | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04859582 | Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02246049 | A Multicenter, Clinical Study of FOLFOXIRI With Bevacizumab As First-line Therapy in Patients With mCRC | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002783 | Combination Chemotherapy Before and After Surgery in Treating Patients With Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01248299 | Benefit of Chemotherapy Over Best Supportive Care in Metastatic and Squamous Cell-type Esophageal Cancer. | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006094 | Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02672917 | Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | kidney cancer | Fluorouracil (NPC75844) | NP level |
NCT00091312 | Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112658 | Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003543 | Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00065117 | Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT02419495 | Selinexor With Multiple Standard Chemotherapy or Immunotherapy Regimens in Treating Patients With Advanced Malignancies | cutaneous melanoma;Fallopian Tube Carcinoma;metastatic melanoma;renal cell carcinoma;non-small cell lung carcinoma;ovarian carcinoma;breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02128100 | Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02551159 | Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00782041 | Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer | uterine neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00555672 | Study Of Sunitinib In Combination With Cisplatin And 5-Fluorouracil In Patients With Advanced Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00166465 | Stage IV Colorectal CA ALIMTA | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02400567 | Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01966471 | A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003594 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03910634 | IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01060007 | Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00055601 | Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT04371224 | NaliCap (Irinotecan Liposome (Nal-IRI)/Capecitabine) vs. NAPOLI (Nal-IRI/5-FU/LV) ) in Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002984 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced or Metastatic Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04094688 | Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003172 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00193219 | Bevacizumab and Cetuximab in Combination With FOLFOX6 in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03881111 | First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)-China Extension Study | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02383966 | Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05209074 | Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00719199 | Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04853199 | Quercetin In The Treatment Of SARS-COV 2 | COVID-19 | Quercetin (NPC20791) | NP level |
NCT00001498 | A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | esophageal cancer;gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00129922 | Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00498953 | Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00001569 | Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis | peritoneal neoplasm;carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00068692 | Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer | mucinous carcinoma;rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01628211 | Second Look Laparoscopy in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01473303 | Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004097 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02987699 | Phase II Study of HAIC Using Cisplatin,Leucovorin and 5-Fluorouracil | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02648711 | Alternative Dosing for CRLX101(NLG207) Alone, With Avastin and With mFOLFOX6 in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00007878 | Bortezomib, Fluorouracil, and Leucovorin Calcium in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01068132 | Prognostic Factors for Patients With Advanced Colorectal Cancer Treated With Cetuximab. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03020329 | Induction Chemotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00773695 | A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04594772 | Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00199797 | Phase I Trial of huA33 Plus Chemotherapy in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00066846 | Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002551 | SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01634555 | A Study to Assess the Pharmacokinetics of Ramucirumab (IMC-1121B) in Combination With FOLFIRI | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01611857 | Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01055743 | The Effect of Fluorouracil Implants Regional Chemotherapy During the Surgical Treatment for Early Stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00820547 | Efficacy and Tolerance Study of Bevacizumab in Her2- Inflammatory Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03803254 | HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01205022 | Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002570 | Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002631 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00026130 | Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04031703 | Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01905150 | Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03110926 | Induction Chemotherapy for Locally Advanced Esophageal Cancer | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02879513 | Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy | inflammatory breast carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02967887 | Evaluation of Hepatic Arterial Infusion of Cisplatin and 5-FU in Biomarker Stratified HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02369939 | Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy | anal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02884128 | A Study of PEP02 in Combination With 5-fluorouracil (5-FU) and Leucovorin (LV) in Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03426904 | Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004252 | Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00413322 | Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02921256 | Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00047099 | Combination Chemotherapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00736944 | Trial of 2 Cycles of Induction Chemo With Abraxane, Cetuximab, Cisplatin, & 5-FU for Advanced Head and Neck Cancer | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00024141 | Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02846428 | To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02019355 | Actinic Keratosis Study | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05009069 | A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01077739 | A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00303758 | Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02340949 | Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02777437 | Laparoscopic Surgery VS Laparoscopic Surgery + Neoadjuvant Chemotherapy for T4 Tumor of the Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00615056 | A Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line Regimen | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00193011 | Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02795988 | A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer | adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01953406 | The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01489865 | ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00642577 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00525785 | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | esophageal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00630032 | Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03421353 | AZD9150 Plus Durvalumab Alone or in Combination With Chemotherapy in Patients With Advanced, Solid Tumours and in Patients With Non-Small-Cell Lung Cancer | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00049101 | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01503372 | FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT04611724 | Neo-adjuvant Short Course Chemo-radiation Therapy in Locally Advanced Rectal Cancer Patients | cancer | Fluorouracil (NPC75844) | NP level |
NCT05015621 | A Phase 3 Study to Evaluate Surufatinib Plus Toripalimab in the Treatment of Advanced Neuroendocrine Carcinoma | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00086996 | S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02319018 | Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors | digestive system cancer | Fluorouracil (NPC75844) | NP level |
NCT02268695 | Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03563170 | QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03192618 | The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Microvascular Invasion (MVI) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00851045 | Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00995293 | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00101894 | Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03326947 | Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC | upper aerodigestive tract neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02115152 | Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02580253 | Adjuvant Chemotherapy Based on the Adenosine Triphosphate Tumor Chemosensitivity Assay for Hepatocellular Carcinoma After Liver Transplantation | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00058474 | Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00612586 | Study of Enzastaurin With 5-Fluorouracil/Leucovorin (5-FU/LV) Plus Bevacizumab as Maintenance Regimen Following First Line Therapy for Metastatic Colon Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00307736 | Bevacizumab, Erlotinib and 5-Fluorouracil With External Beam Radiation Therapy in Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04961970 | HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01914900 | Preoperative TPF Chemotherapy in a Population of Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00943137 | The Optimization of 5-Fluorouracil Dose by Pharmacokinetic Monitoring in Asian Patients With Advanced Stage Cancer | cancer | Fluorouracil (NPC75844) | NP level |
NCT00705016 | Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02767219 | The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery | glaucoma | Fluorouracil (NPC75844) | NP level |
NCT00014222 | Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00079274 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | colorectal adenocarcinoma;malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00070122 | Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03732508 | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer | squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03042780 | FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas | pancreatic endocrine carcinoma;pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04589234 | Saltikva for Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Fluorouracil (NPC75844) | NP level |
NCT00988897 | Colorectal Cancer RECHALLENGE | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00873275 | Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02141295 | A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00182715 | Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02845908 | POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01270373 | NeoSAMBA: Neoadjuvant: Does the Sequence of Anthracycline and Taxane Matters: Before or After? | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT02735239 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00000758 | A Phase III Randomized Trial of Topical Vaginal Fluorouracil (5-Fluorouracil, 5-FU) Maintenance Therapy Versus Observation After Standard Treatment for High-Grade Cervical Dysplasia in HIV-Infected Women | dysplasia of cervix | Fluorouracil (NPC75844) | NP level |
NCT00611507 | A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004164 | Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00010075 | Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02325986 | Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00955240 | Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT02887313 | FOLFOX6 Totally Neoadjuvant Chemoradiation Therapy in Locally Advanced Rectal Cancer: A Real World Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03081143 | Ramucirumab Plus FOLFIRI Versus Ramucirumab Plus Paclitaxel in Patients With Advanced or Metastatic Gastric Cancer, Who Failed One Prior Line of Palliative Chemotherapy | gastric carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01992705 | Borderline Pancreas Study: FOLFIRINOX +SBRT | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00316888 | Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00849264 | Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma Patients | thrombotic disease;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00665392 | Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00525915 | Oxaliplatin-Based Chemotherapy and Chemoradiotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Carcinoma | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00193141 | Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02024607 | BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC) | cancer | Fluorouracil (NPC75844) | NP level |
NCT00857246 | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02355379 | Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over | colon adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT04325425 | Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary | neuroendocrine carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05083247 | Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma | pancreatic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT01269229 | A Trial of Neoadjuvant FOLFOX6 With Short Course Radiotherapy in Patients With Unresectable Rectal Cancer and Liver Metastasis | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05213312 | Study of Neoadjuvant Nivolumab or Placebo Plus Chemotherapy Followed by Surgery and Adjuvant Treatment in Subjects With Resectable ESCC | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00384176 | First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02365805 | Randomized CT to Evaluate Efficacy of Neoadjuvant Chemotherapy Customized by Levels of BRCA1-HER2 Negative Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03668730 | Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00069108 | A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00303771 | Combination Chemotherapy as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02616601 | Multicenter, Double-blind, Placebo Controlled Comparing Test Fluorouracil Cream to Carac Cream in Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT03484195 | Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer | colonic neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00309569 | Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05166772 | Donafenib Combine With Sintilimab and HAIC (Hepatic Artery Infusion Chemotherapy,HAIC)in the First-line Treatment of Unresectable Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03002064 | Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00719797 | Combination Chemotherapy and Bevacizumab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01704703 | Study of FOLFIRI + Panitumumab Using Ultra-selection Technology of Patients With Stage IV Colorectal Cancer Refractory to Irinotecan Without Any Mutation on KRAS, PIK3Ca, BRAF and NRAS Genes Detected With Highly Sensitive Techniques | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00143403 | Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer | colorectal neoplasm;hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05065801 | Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02969473 | Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma | neoplasm of esophagus | Fluorouracil (NPC75844) | NP level |
NCT02923921 | Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00463840 | Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02442362 | TOF Versus SOX in Metastatic Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT05035381 | PD-1 Inhibitor Combined With Bevacizumab and FOLFIRI Regimen in the Second-line Treatment of Advanced Colorectal Cancer | colorectal cancer | Fluorouracil (NPC75844) | NP level |
NCT01567618 | Dose-dense Biweekly Docetaxel Combined With 5-fluorouracil as First-line Treatment in Advanced Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02885753 | Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00016978 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Previously Treated With Irinotecan | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04164238 | Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC Patients | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04480190 | Neoadjuvant Therapy in Biliary Adenocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03883802 | Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00129389 | FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01225523 | Perioperative Vs. Preoperative Chemotherapy With Surgery in the Squamous Carcinoma of Esophagus | esophageal squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00124111 | A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003254 | SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00400179 | A Safety and Efficacy Study in Patients With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01515787 | PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006472 | Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00072553 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02376452 | Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01941641 | Colon Neoadjuvant FOLFOXIRI Study | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04851821 | The Effectiveness of Phytotherapy in SARS-COV2(COVID-19) | COVID-19 | Quercetin (NPC20791) | NP level |
NCT01111604 | A Study of Ramucirumab or Icrucumab in Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT04502641 | Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial | hypopharyngeal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00210184 | Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02527772 | Liposomal Doxorubicin Plus Gemcitabine Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01133990 | FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05493332 | HAIC Combined With Donafenib Tosilate and Toripalimab for Unresectable HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00112697 | Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02226484 | Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? | gastroesophageal reflux disease | Quercetin (NPC20791) | NP level |
NCT00006103 | Combination Chemotherapy in Treating Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03484221 | Totally Neoadjuvant FOLFOXIRI + Short-course Radiation + XELOX in Patients With Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT03340896 | Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00193284 | Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT03443492 | SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01302613 | Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02280070 | RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301). | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00006786 | Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00313872 | Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00423293 | Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT00696488 | Measuring Adherence To Topical 5-Fluorouracil in a Clinic Population | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT04875026 | Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT03727061 | Porfimer Sodium Interstitial Photodynamic Therapy With or Without Standard of Care Chemotherapy in Treating Patients With Locally Advanced or Recurrent Head and Neck Cancer | head and neck carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003029 | Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00309543 | Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04808323 | MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00981656 | Radiation Therapy and Chemotherapy in Treating Patients With Stage I Bladder Cancer | urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT01324141 | Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer | anus cancer | Fluorouracil (NPC75844) | NP level |
NCT01467115 | Induction Chemotherapy Followed by Cetuximab and Radiation Therapy for Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00278694 | Oxaliplatin and 5-FU Based Preoperative Chemoradiation | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00865189 | A Study of Bevacizumab (Avastin) in Participants With Newly Diagnosed Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | peritoneum cancer | Fluorouracil (NPC75844) | NP level |
NCT02355119 | Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00971932 | Study of Cetuximab in Combination With Chemotherapy in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN) | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00973609 | Optimal Maintenance Therapy With Bevacizumab After Induction in Metastatic Colorectal Cancer (CRC) | colorectal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT01222052 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT04390399 | Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02942563 | Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00471484 | Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery | liver cancer | Fluorouracil (NPC75844) | NP level |
NCT01198392 | Trial of S-1 Plus Cisplatin in Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02681003 | 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT03167112 | A Study of Administering FOLFIRINOX Before Surgery For Potentially Curable Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00152178 | The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC) | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00066274 | Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00963729 | Chemotherapy or Letrozole Before Surgery in Treating Postmenopausal Women With Breast Cancer That Can Be Removed By Surgery | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00235898 | Clinical Trial in Patients With Metastatic Colorectal Cancer | malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00005586 | Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00349076 | Neoadjuvant Chemoradiotherapy and Adjuvant Chemotherapy With 5-Fluorouracil and Oxaliplatin Versus 5-Fluorouracil Alone in Rectal Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT05229497 | FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC | cancer | Fluorouracil (NPC75844) | NP level |
NCT00514020 | Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00455416 | Dietary Intervention in Follicular Lymphoma | follicular lymphoma | Quercetin (NPC20791) | NP level |
NCT02494973 | Postoperative Hepatic Arterial Chemotherapy in High-risk Patients as Adjuvant Treatment After Resection of Colorectal Liver Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00507091 | Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT05108428 | Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00323583 | Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02973685 | HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00003118 | Surgery With or Without Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01769508 | Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03785873 | Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT00646607 | FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00002828 | Chemotherapy With Raltitrexed and Fluorouracil in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00068575 | Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002525 | Perioperative Chemotherapy in Treating Patients With Colon Cancer That Can Be Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03771846 | HAIC Versus Systemic Chemotherapy for Unresectable ICC | intrahepatic cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01937507 | Hepatic Artery Infusion With FOLFOX in Liver Metastasis From Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00933816 | Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00002581 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02047201 | Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT04908566 | Immune Checkpoint Inhibitor PD-1 Antibody Combined With Chemotherapy in the Perioperative Treatment of Locally Advanced Resectable Gastric or Gastroesophageal Junction Adenocarcinoma | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01193452 | S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00468169 | Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00632333 | Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04003792 | Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Inoperable Liver-only CRLM. | malignant colon neoplasm | Fluorouracil (NPC75844) | NP level |
NCT04165772 | Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02919787 | Nordic Pancreatic Cancer Trial (NorPACT) - 1 | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00069953 | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT02311439 | Induction Chemotherapy, FOLFIRINOX Followed With Concurrent Capecitabine and Radiation Therapy in Inoperable Locally Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03152370 | Preoperative Radiotherapy and E7046 in Rectum Cancer | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002955 | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04356170 | Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00038402 | Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00862784 | A Study of IMC-1121B (Ramucirumab) in Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00541112 | Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02243007 | Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02456714 | Second Line Chemotherapy FOLFIRINOX in Irresectable Cholangiocarcinoma | cholangiocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01633970 | A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT04854499 | Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03130790 | Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line) | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03487016 | First-line Therapy in Metastatic PDAC | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02124148 | A Study of Prexasertib (LY2606368) With Chemotherapy or Targeted Agents in Participants With Advanced Cancer | colorectal neoplasm;metastasis | Fluorouracil (NPC75844) | NP level |
NCT00270543 | An Effective and Well-Tolerated Regimen of Docetaxel Plus High-Dose 5-Fluorouracil and Leucovorin(HDFL)to Treat Inoperable Advanced or Metastatic Gastric Cancer | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00817583 | Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma (NPC) | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02281682 | IM Versus 5-FU Versus IMI Versus MAL-PDT in Treatment of Actinic Keratosis | actinic keratosis | Fluorouracil (NPC75844) | NP level |
NCT01560949 | Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00090025 | XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors | biliary tract cancer | Fluorouracil (NPC75844) | NP level |
NCT04510064 | PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00544362 | Fluorouracil, Cisplatin, Cetuximab, and Radiation Therapy in Treating Patients With Esophageal Cancer That Can Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00043121 | Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By Surgery | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00004257 | Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT00122460 | Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00002593 | S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01998347 | Paclitaxel Liposome and Cisplatin as First-line Chemotherapy in Patients With Metastatic Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01270438 | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00615602 | Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00003873 | Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00499850 | Phase I FOLFOX Combination | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT03069950 | Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00103103 | Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03306121 | TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT02648425 | Safety and Tolerability of ASLAN001 in Combination With Cisplatin and 5-FU or Cisplatin and Capecitabine | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00387387 | Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin) | colorectal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT01216644 | 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT00433420 | Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT02132949 | A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00025337 | Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated | colorectal adenocarcinoma;malignant colon neoplasm;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00002696 | Combination Chemotherapy in Treating Women With Stage III Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT05111860 | Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT00872625 | Radiation Therapy and Docetaxel Followed by Standard Therapy in Treating Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT00323011 | FOLFIRI + Bevacizumab With or Without Dalteparin in First Line Treatment of Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03812783 | HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01442935 | Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006051 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00393068 | Chemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT01086826 | Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck | head and neck squamous cell carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02641691 | Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum | rectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC) | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05074966 | The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts | rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT01946074 | A Study of ABT-165 in Subjects With Solid Tumors | neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03943459 | Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease | coronary artery disease | Quercetin (NPC20791) | NP level |
NCT05135364 | HAIC Combined With Camrelizumab and TKI for Unresectable Hepatocellular Carcinoma After TACE Failure | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT03342352 | Nivolumab Plus Epacadostat in Combination With Chemotherapy Versus the EXTREME Regimen in Squamous Cell Carcinoma of the Head and Neck (CheckMate 9NA/ECHO-310) | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
NCT00201396 | A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT03605706 | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Have Never Received Prior Systemic Treatment. | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00697905 | Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma | nasopharyngeal neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00045747 | UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT01652482 | Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006468 | Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02415699 | DC-CIK Immunotherapy Plus Chemotherapy vs Chemotherapy Alone in the Adjuvant Treatment of Stage III Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00499603 | Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer | breast cancer | Fluorouracil (NPC75844) | NP level |
NCT01526135 | Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02755311 | Liver Resection Versus Transarterial Chemoembolization for the Treatment of Intermediate-stage Hepatocellular Carcinoma | hepatocellular carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02142322 | Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT01490866 | A Trial of Single Agent Axitinib as Maintenance Therapy for Patients With First Line Metastatic Colorectal Cancer (mCRC) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT05329766 | A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors | cancer | Fluorouracil (NPC75844) | NP level |
NCT02625610 | Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) | gastric adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT00055822 | Combination Chemotherapy and Oblimersen in Treating Patients With Advanced Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00539617 | Chemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by Surgery | esophageal cancer | Fluorouracil (NPC75844) | NP level |
NCT04469556 | Pancreatic Adenocarcinoma Signature Stratification for Treatment | pancreatic ductal adenocarcinoma | Fluorouracil (NPC75844) | NP level |
NCT02578368 | Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT03600623 | Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006115 | Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT02574663 | TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors | gastrointestinal stromal tumor;esophageal cancer;gastric cancer;pancreatic carcinoma;rectum cancer | Fluorouracil (NPC75844) | NP level |
NCT02591030 | Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours | bile duct cancer | Fluorouracil (NPC75844) | NP level |
NCT03067792 | FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer | gastric cancer | Fluorouracil (NPC75844) | NP level |
NCT02486601 | NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma | stomach neoplasm | Fluorouracil (NPC75844) | NP level |
NCT00059826 | Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer | pancreatic carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00006111 | Surgery Plus Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Urinary Tract | urethra cancer;urinary bladder cancer | Fluorouracil (NPC75844) | NP level |
NCT00526110 | Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | gastrointestinal disease | Fluorouracil (NPC75844) | NP level |
NCT01286818 | A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) | colorectal carcinoma | Fluorouracil (NPC75844) | NP level |
NCT00004094 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx | head and neck malignant neoplasia | Fluorouracil (NPC75844) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Ovarian cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73 |
CHEK1,FLT3,TP53,MET,SRC,TOP1,KDR
NCT00004206,NCT03197584 |
Malignant neoplasms of rectum, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92.Z |
NCT04749108,NCT04703101,NCT01804790,NCT02000050,NCT01383343,NCT01333709,NCT00068692,NCT00308516,NCT02641691
|
Malignant neoplasms of thyroid gland, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10.Z |
CA7,CYP1B1,NOX4,CA12,MET,ALOX5,DPP4,SSTR3,XDH
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CHEK1,AURKB,ALOX15,NPSR1,CYP1A1,CDK1,CYP2C9,XDH,HSD17B2
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
CISD1,CYP1B1,ALOX15,FLT3,HSD17B10,DPP4,GMNN,CYP2C9,HSD17B2
|
Malignant neoplasms of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
HBB
NCT00002883,NCT04937738,NCT04358354,NCT00149201,NCT00374036,NCT02574663,NCT00210184,NCT02296671,NCT00188266,NCT00384878,NCT00004099,NCT00595972,NCT00002722,NCT04354662,NCT03939962,NCT03694522,NCT02934464,NCT00003172,NCT00711243,NCT00514020,NCT00202969,NCT01590719,NCT00555672,NCT01924819,NCT03606928,NCT03825861,NCT01896531,NCT03130790,NCT01286766,NCT00003862,NCT02486601,NCT00270543,NCT00052910,NCT00313872,NCT00142350,NCT05319639,NCT03015675,NCT02114359,NCT04859582,NCT02563054,NCT04358341,NCT00103103,NCT00004873,NCT00941655,NCT02442362,NCT00857246,NCT04757363,NCT01662869,NCT00447967,NCT00155883,NCT04379596,NCT01283204,NCT00002615,NCT02578368,NCT01889303,NCT00611507,NCT00054873,NCT00976768,NCT01503372,NCT03067792,NCT04997837,NCT00020787,NCT03607656,NCT03675737,NCT01041404,NCT00525785,NCT04155671,NCT00002783,NCT01183559,NCT04393584,NCT01216644,NCT01198392,NCT00005060,NCT02845908,NCT01769508,NCT04149015,NCT00123318,NCT00400179,NCT00811447,NCT00004233,NCT00003298,NCT02142322,NCT01851941,NCT00343239,NCT01774786,NCT00215514,NCT00992199,NCT01285557 |
Multiple myelomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A83 |
IGF1R,SRC,MTOR,AHR,AXL,KDR,FLT3
NCT00003331 |
Myelodysplastic syndromeDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A37 |
KDR,AHR,AXL,TOP1,TP53,EGFR
NCT00003331 |
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
HIF1A,EGFR,TOP1,SRC,MET,KDR,TP53
|
Malignant haematopoietic neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33 |
CDK1,MTOR,DPP4,FLT3,AURKB,SRC,TP53
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
HIF1A,CHEK1,TOP1,EGFR,MTOR
NCT00001579,NCT00003956 |
Renal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
MET,EGFR,MTOR,TOP1,KDR
NCT02419495,NCT00083109 |
Malignant neoplasm metastasis, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E2Z |
NCT00126256,NCT00289445,NCT02419495,NCT02124148,NCT00065117,NCT00149201,NCT00374036
|
Malignant neoplasms of oesophagusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
CHEK1,AURKB,NOX4,NPSR1,CDK1,ALOX15
NCT02969473 |
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
TUBB6,CYP1B1,NOX4,THPO,HTR2B,DPP4,HBB
|
Esophageal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B70 |
TP53,TOP1
NCT00008047,NCT03110926,NCT01998347,NCT00054873,NCT01608464,NCT03279237,NCT00861094,NCT00381706,NCT02359968,NCT00002883,NCT00416858,NCT03910634,NCT01843049,NCT01372202,NCT00632333,NCT00735345,NCT00003118,NCT03881111,NCT00539617,NCT00193141,NCT03764553,NCT03281369,NCT01348217,NCT00193882,NCT00041262,NCT01183559,NCT00075738,NCT02574663,NCT01611857,NCT01217060,NCT00259402,NCT00021320,NCT00230451,NCT00160030,NCT00002631,NCT00002984,NCT00425425,NCT00525915,NCT00258323,NCT02735239,NCT02023593,NCT00733889,NCT00086996,NCT00551759,NCT03189719,NCT03002064,NCT00570531,NCT00209716,NCT00002897,NCT01787006,NCT00002884,NCT00544362,NCT00393068,NCT00004233,NCT00209690,NCT00004897,NCT00020787,NCT00915850,NCT00047112,NCT00759226,NCT00006472,NCT01704690,NCT00004257,NCT00052910,NCT00069953 |
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
CHEK1,EGFR,MTOR,KDR,TP53,MET
NCT01081041,NCT00721513,NCT01467115,NCT00122460,NCT00003576,NCT00460265,NCT00006248,NCT00004094,NCT00646659,NCT00052429,NCT00003627,NCT02358031,NCT00002999,NCT00002839,NCT00193284,NCT00665392,NCT00113399,NCT00498953,NCT01126216,NCT00093665,NCT01142414,NCT00004901,NCT00203905,NCT00468169,NCT00004865,NCT01911598,NCT00004097,NCT00004164,NCT00054054,NCT04356170,NCT00002496,NCT03386838,NCT02353260,NCT00004089,NCT00352118,NCT00002476,NCT00003637,NCT00003888,NCT03358472,NCT00002735,NCT02741570,NCT00268372,NCT00608205,NCT00352105,NCT00002747,NCT00392704,NCT00003777,NCT03727061,NCT04428333,NCT00095875,NCT00544414,NCT00868491,NCT00006051,NCT03342352,NCT00002888,NCT02997332 |
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT02720068,NCT00413322,NCT01522989,NCT00448136,NCT00261703,NCT04420884,NCT01946074,NCT03326947,NCT04047862,NCT00021073,NCT00215501,NCT02723955,NCT00004059,NCT03085914,NCT00954512,NCT00838370,NCT03250832,NCT00020488,NCT00005791,NCT00080990,NCT00502567,NCT01047007,NCT02715531,NCT04151277,NCT00044785,NCT00004913,NCT02648711,NCT00042861,NCT01362374,NCT00004242,NCT01634555,NCT01472016,NCT02482441,NCT01930552,NCT00024141,NCT00042874,NCT00005068,NCT00402545,NCT00246103,NCT00289445,NCT00995293,NCT04607421,NCT04176952,NCT00357149,NCT03577704,NCT00007878,NCT04541108,NCT00043121,NCT03421353,NCT04185883,NCT02817113,NCT02884128,NCT01566435,NCT01099358,NCT00610948,NCT02648425,NCT01206465,NCT03503604,NCT00811993,NCT04393298,NCT02588105
|
Peritoneal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C51 |
TP53,SRC,KDR,FLT3
NCT00352755,NCT00001569 |
Non-small cell lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
EGFR,MET,KDR
NCT02419495,NCT03574649,NCT03169738 |
Acute myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A60 |
AXL,SRC,AURKB,PIM1,TP53,FLT3
|
Pancreatic cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
SRC,MTOR,IGF1R,TP53,EGFR,CHEK1
|
Malignant neoplasms of bladder, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.Z |
NCT00003642,NCT00024349,NCT00055601,NCT00981656,NCT00003175,NCT00006111
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
TUBB6,SRC,DPP4,PMP22,LMNA,RAB9A
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
EGFR,AXL,HIF1A,CYP19A1,XDH,LMNA
|
Hepatocellular carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH4W48 |
NCT03605706,NCT03468231,NCT00849264,NCT01327521,NCT03869034,NCT02967887,NCT03780634,NCT03563170,NCT03192618,NCT03780049,NCT02527772,NCT00921531,NCT01953406,NCT05214339,NCT01775501,NCT02534337,NCT03722498,NCT00143403,NCT02774187,NCT03469479,NCT03192644,NCT00933816,NCT02973685,NCT02981498,NCT02069041,NCT01055743,NCT05263219,NCT04994236,NCT02767375,NCT03048123,NCT03812783,NCT05135364,NCT05033522,NCT01171482,NCT04962958,NCT05171166,NCT00619541,NCT00471965,NCT02755311,NCT00559455,NCT02987699,NCT02452853,NCT03803254,NCT03812770,NCT02426450,NCT05493332,NCT05029973,NCT02580253,NCT05476432,NCT05166772
|
Metastatic digestive system neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D8Y |
SRC
NCT03800693,NCT01434069,NCT04755543,NCT02319018 |
Stomach cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72 |
MET,TOP1,EGFR,KDR,TP53
|
MelanomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
EGFR,MET,KDR,TYR
NCT03167177 |
Cervical cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C77 |
TP53,SRC
NCT00023660,NCT00003209,NCT00003078 |
Malignant neoplasm of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10 |
NCT01121848,NCT01413022,NCT05083247,NCT00417209,NCT00220649
|
Neoplasms of unknown behaviour of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F95 |
NCT00174707,NCT01220128,NCT01779050,NCT00429299,NCT00121992
|
Malignant neoplasms of stomach, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.Z |
NCT01748851,NCT02048540,NCT00509964,NCT03081143,NCT00237900
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT05348811,NCT04480190,NCT03603834,NCT05024513,NCT02456714
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
TSHR,NOX4,FLT3,DPP4,SSTR3
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
TYR,NOX4,MET,NPSR1,CYP1A1
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
CHEK1,AURKB,CYP1A2,CYP2C9,CDK1
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
CHEK1,AURKB,CA12,THPO,CDK1
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
AURKB,CA12,CYP1A2,MET,CYP1A1
|
Metastatic lymph node neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60 |
MTOR,EGFR,MET,KDR
|
Pleomorphic sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B54 |
SRC,KDR,MTOR,MET
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
ALOX5,FLT3,DPP4,AHR
|
Hypopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6D |
EGFR
NCT04502641,NCT01312350,NCT00508664 |
Mature B-cell leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A82 |
EGFR,AXL,TP53,SRC
|
Gastrointestinal stromal tumourDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5B |
TOP1,KDR,SRC
NCT02574663 |
Malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90 |
NCT00003585,NCT00053807,NCT00003664,NCT00053820
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
NOX4,MET,SSTR3,XDH
|
Osteoarthritis, unspecifiedDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA0Z |
CA12,CDK1,HBB,HSD17B2
|
West Nile virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D46 |
AXL,MET,DPP4,CYP19A1
|
Melanoma of skinDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30 |
NOX4,IGF1R,SSTR3,ABCG2
|
Other specified malignant neoplasms of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.Y |
AURKB,CA12,CDK1,XDH
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
THPO,CYP1A1,CYP2C9,ALOX15
|
Malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
NCT00025337,NCT00193219,NCT01198548,NCT01383343,NCT01238965,NCT00070122,NCT02041481,NCT00337389,NCT01270438,NCT04488159,NCT00499369,NCT00101894,NCT04120701,NCT03883802,NCT04259944,NCT02967289,NCT03426904,NCT01111604,NCT00003835,NCT04003792,NCT00003873,NCT01205022,NCT01347645,NCT00646607,NCT05062889,NCT00235898,NCT03641976,NCT02510118,NCT00004931,NCT05174169,NCT00079274,NCT00309543,NCT04303429,NCT05179889,NCT02138617,NCT04832776,NCT00309530,NCT00942266
|
Squamous cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B60-2D01 |
NCT01391572,NCT01225523,NCT01591135,NCT03732508,NCT05221658,NCT03387111,NCT05125055,NCT02459457,NCT02218164,NCT04926753,NCT02325986,NCT02383966,NCT01248299,NCT00705016,NCT02485548,NCT04229459,NCT03783442,NCT01181401,NCT05213312,NCT01836029,NCT01914900,NCT05469061,NCT03748134,NCT03370406,NCT03109158,NCT04550260,NCT04649476,NCT04949256,NCT04460352,NCT03224221,NCT04839731,NCT01627379,NCT01542931,NCT02017600
|
AdenocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D40 |
NCT00307723,NCT03970252,NCT01526135,NCT02468557,NCT05472259,NCT00054873,NCT04292743,NCT04821284,NCT02440958,NCT03977233,NCT02795988,NCT04752696,NCT05314998,NCT04793932,NCT05257993,NCT02243007,NCT05132504,NCT01893294,NCT04469556,NCT04990037,NCT02959879,NCT03806309,NCT03331640,NCT04481204,NCT01676259,NCT05209074,NCT02178709,NCT04539808,NCT00548548,NCT04927780
|
NADisease Category: NADisease ICD-11 Code: NA |
NOX4,MET
NCT00217737 |
Nasopharyngeal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
ALOX5,CDK1,EGFR
|
Thyroid cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D10 |
TSHR,KDR,MET
|
Alzheimer diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A20 |
KDR,MET,FLT3
|
Cardiovascular diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA00-BE2Z |
KDR,MET,SRC
|
Pain, unspecifiedDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG3Z |
IGF1R,ALOX5,MTOR
|
Bacterial infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-1C4Z |
CYP2C9,CA12,TOP1
|
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
HIF1A,HTR2B,MTOR
|
Chronic arterial occlusive diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD4Z |
MET,TP53,DPP4
|
ThrombocytopeniaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3B64 |
AHR,KDR,ALOX5
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
AURKB,DPP4,KDR
|
Chronic painDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG30 |
KDR,EGFR,FLT3
|
Pituitary gland disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A60-5A61 |
ALOX5,HTR2B,IGF1R
|
Mature B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A85 |
FLT3,TOP1,CDK1
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
IGF1R,XDH
NCT02848131 |
Lip/oral cavity/pharynx neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6E |
TP53
NCT00117572,NCT00117572 |
Endometrial cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
TP53,MTOR,SRC
|
Urethral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C93 |
EGFR
NCT00006111,NCT00003175 |
GlaucomaDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C61 |
MET
NCT02767219,NCT00000122 |
Adenocarcinoma of prostateDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82.0 |
NOX4,ALOX15
NCT01912820 |
Coeliac diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA95 |
TSHR,CYP1A1,CDK1
|
Myelodysplastic syndromes, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A3Z |
TSHR,PIM1,CYP2C9
|
Human immunodeficiency virus disease without mention of tuberculosis or malariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C62 |
AXL,FLT3,MET
|
Ebola virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D60.01 |
AXL,HSD17B2,MET
|
Malignant neoplasms of nasopharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6B |
NCT03668730,NCT01536223,NCT00379262,NCT00817583,NCT02012062,NCT03503136,NCT00188877,NCT04437329,NCT03175939,NCT02500940,NCT02434614,NCT00592501,NCT01528618,NCT02590133,NCT04004871,NCT02016417,NCT03306121,NCT00677118,NCT03574324,NCT00816816,NCT05433597,NCT00816855,NCT01245959,NCT00747799,NCT00697905,NCT03020329,NCT03604965,NCT04834206,NCT00201396
|
Other specified malignant neoplasms of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
NCT01277406,NCT00707889,NCT00079274,NCT00003835,NCT00942266,NCT02508077,NCT04068103,NCT03069950,NCT00096278,NCT01704703,NCT03300609,NCT01383343,NCT00387387,NCT00851045,NCT02071069,NCT02355379,NCT01862003,NCT01270438,NCT00166465,NCT03050814,NCT00507091,NCT01605344,NCT00003873,NCT00499850,NCT00070122,NCT00967616,NCT02413853,NCT04094688,NCT00025337
|
Unspecified malignant neoplasms of unspecified sitesDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D4Z |
NCT00479583,NCT01750918,NCT00941499,NCT03143153,NCT05235542,NCT00500292,NCT05229497,NCT01046864,NCT02640365,NCT01653470,NCT05217069,NCT05332002,NCT01332604,NCT04370418,NCT02024607,NCT03368859,NCT05329766,NCT04733534,NCT00983541,NCT01633970,NCT00943137,NCT03082209,NCT02937116,NCT00710736,NCT04611724,NCT01183663
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
CISD1,SRC,HTR2B,TP53,PMP22,RECQL,AHR,EGFR,AURKB,SMN1,HSD17B10,CSNK2A2,GMNN,CDK1,CHEK1,TUBB6,NOX4,MET,SSTR3,CA12,AXL,THPO,KDR,TSHR,LMNA
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
CA7,SRC,DPP4,XDH,TOP1,HSD17B2,RECQL,AHR,EGFR,AURKB,SMN1,CSNK2A2,GMNN,CDK1,MET,FLT3,SSTR3,ALOX15,PIM1,TYR,CA12,AXL,ALOX5,KDR,LMNA
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
CA7,CISD1,POLB,HTR2B,PMP22,DPP4,XDH,TOP1,HSD17B2,RECQL,AURKB,CYP1B1,HIF1A,CYP2C9,CHEK1,TUBB6,MET,ALOX15,PIM1,ABCG2,AXL,NPSR1,ALOX5,LMNA
|
Colorectal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B91 |
EGFR,TP53,IGF1R,KDR,FLT3,MET,TOP1
NCT00066274,NCT00002570,NCT02291289,NCT00642577,NCT00831181,NCT00110721,NCT00862784,NCT00551213,NCT00098982,NCT00427310,NCT00020917,NCT01167725,NCT00839111,NCT00265850,NCT00002893,NCT05193292,NCT00884767,NCT00023751,NCT00749450,NCT00025142,NCT00202787,NCT00209703,NCT00813137,NCT00006786,NCT00303771,NCT00265811,NCT00449137,NCT01442649,NCT00280176,NCT01622543,NCT00075595,NCT01478594,NCT00286000,NCT00628810,NCT00559741,NCT00354978,NCT00003287,NCT00176774,NCT00003543,NCT02830139,NCT00284258,NCT00016198,NCT00454116,NCT00003001,NCT00004150,NCT02375672,NCT00143403,NCT00006468,NCT01417494,NCT01652482,NCT01529164,NCT01375816,NCT01279681,NCT01383707,NCT00046995,NCT00008281,NCT01736904,NCT00478946,NCT00278889,NCT02826837,NCT00066846,NCT00008060,NCT02244632,NCT02515734,NCT00378716,NCT00721916,NCT00091312,NCT00016978,NCT01326000,NCT05239741,NCT01286818,NCT00615056,NCT00002523,NCT00021281,NCT00001428,NCT01802645,NCT00613080,NCT00797485,NCT00720512,NCT00296608,NCT00002828,NCT00349336,NCT01765582,NCT01374425,NCT03487939,NCT00873275,NCT00469443,NCT00062426,NCT00061815,NCT02415699,NCT00039208,NCT00577109,NCT00388700,NCT01263171,NCT00070434,NCT00058474,NCT01628211,NCT00003063,NCT00778102,NCT00671372,NCT00065117,NCT00182715,NCT00988897,NCT00268333,NCT00004252,NCT00003254,NCT00004885,NCT02124148,NCT01836653,NCT00069108,NCT00497497,NCT00003422,NCT00501410,NCT02246049,NCT00027833,NCT00005586,NCT01068132,NCT00647530,NCT00940303,NCT00016133,NCT00541125,NCT00467142,NCT01205711,NCT01047293,NCT00069121,NCT00002716,NCT01718873,NCT00072553,NCT00081289,NCT00609622,NCT05253651,NCT01490866,NCT00069095,NCT00268398,NCT00080951,NCT00202774,NCT00016952,NCT00005979,NCT00786643,NCT00055822,NCT01271166,NCT00021398,NCT00209625,NCT00126256,NCT00423696,NCT02376452,NCT00077233,NCT00889343,NCT00003260,NCT00003594,NCT00006479,NCT00544011,NCT01679327,NCT00384176,NCT00719797,NCT00002593,NCT00002793,NCT01193452,NCT00002525,NCT00556413,NCT00098787,NCT01465451,NCT00112918,NCT00049101,NCT00612586,NCT00958737,NCT00537823,NCT02842580,NCT00003446,NCT00020501,NCT02885753,NCT00002551,NCT01226719,NCT00427570,NCT01183780,NCT00004102,NCT02494973,NCT00006037,NCT00336960,NCT04337879,NCT00321828,NCT00009737,NCT00085163,NCT00291785,NCT00006015,NCT00006115,NCT00118261,NCT01150045,NCT00323011,NCT00070213,NCT05081687,NCT01289821,NCT00199797,NCT00952029,NCT00023868,NCT02384850,NCT00111761,NCT00335816,NCT00425152,NCT01442935,NCT00571740,NCT01338558,NCT01133990,NCT01515787,NCT00541112,NCT00385021,NCT00004005,NCT00006366,NCT05035381,NCT01418222,NCT00026273,NCT00262808,NCT01276379,NCT00064181,NCT00640081,NCT02141295,NCT01077739,NCT00002692,NCT00274872,NCT00006103,NCT00755118,NCT00005050,NCT00212589,NCT00719199,NCT00866944,NCT00026364,NCT01479465,NCT01227707,NCT00973609,NCT00002896 |
Malignant neoplasm metastasis in lymph nodes of head, face or neckDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D60.0 |
AURKB,NOX4,NPSR1
NCT00971932,NCT01154920,NCT02268695,NCT00513383,NCT03169764,NCT00139269,NCT01086826,NCT05446467,NCT02551159,NCT00999700,NCT04854499,NCT00274937,NCT01177956,NCT00736944,NCT04164238,NCT01233843,NCT03340896,NCT00002774,NCT03855384,NCT02047201 |
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
AHR,IGF1R,CSNK2A1,XDH,SRC,AXL,CHEK1,MET,YES1,CDK1,ALOX5,AURKB,HIF1A,FLT3,TOP1,CA12,KDR,EGFR,TP53,PIM1,MTOR,POLB
|
Adenocarcinoma of stomachDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B72.0 |
CHEK1,AURKB,NOX4,ALOX15,MET,NPSR1,CDK1,CYP19A1
NCT00183911,NCT03959293,NCT04908566,NCT04510064,NCT04675983,NCT02494583,NCT05268510,NCT01567618,NCT03281369,NCT02625610,NCT04523818,NCT02545504 |
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
ALOX12,DPP4,XDH,TOP1,HSD17B2,AHR,SMN1,HIF1A,GMNN,CDK1,CYP2C9,CHEK1,NOX4,MET,ABCG2,CA12,NPSR1,ALOX5,KDR,RAB9A
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
Motor neuron diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60 |
SRC,IGF1R
|
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
ALOX5,AHR
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
ABCG2,ALOX5
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
CYP19A1,SSTR3
|
Unspecific body region injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND56 |
MET,EGFR
|
BCR-ABL1-negative chronic myeloid leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A41 |
FLT3,SRC
|
Malignant digestive organ neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C11 |
SRC,KDR
|
Transplant rejectionDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NE84 |
MTOR,TP53
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
THPO,DPP4
|
Fallopian tube cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74 |
TP53,SRC
|
IschemiaDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B10-8B11 |
EGFR,SRC
|
InfluenzaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E30-1E32 |
ALOX5,XDH
|
Myeloproliferative neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A20 |
FLT3,SRC
|
Human immunodeficiency virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C60-1C62 |
FLT3,TOP1
|
Malignant mesenchymal neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5D-2B5Y |
MTOR,EGFR
|
Bladder cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94 |
MTOR,TP53
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
AURKB,MTOR
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
ALOX5,RAB9A
|
Chronic myelomonocytic leukaemiaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A40 |
FLT3,MTOR
|
Idiopathic interstitial pneumonitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB03 |
ALOX5,FLT3
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
DPP4
NCT01839344 |
Metastatic liver/bile duct neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D80 |
TP53
NCT02591030 |
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
ALOX5,SRC
|
Neoplasms of unknown behaviour of larynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F91.0 |
NCT00117572,NCT00599131
|
Intrahepatic cholangiocarcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.10 |
NCT04961970,NCT03771846
|
Malignant lymphoma, not elsewhere classifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B33.5 |
NCT03169790,NCT03013218
|
Diseases of the digestive system, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DE2Z |
NCT00208936,NCT00526110
|
Neoplasms of unknown behaviour of colonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F90.0 |
NCT02777437,NCT03484195
|
Skin cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30-2C37 |
NCT00003549,NCT03167164
|
Neoplasms of unknown behaviour of urinary organsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F98 |
NCT04241185,NCT02710734
|
Neuroendocrine neoplasms of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.1 |
NCT03042780,NCT03736720
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT03943459,NCT04907253
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NCT01708278,NCT03989271
|
Inflammatory carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C62 |
NCT02879513,NCT01880385
|
Ageing associated decline in intrinsic capacityDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MG2A |
NCT04946383,NCT05422885
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04851821,NCT04853199
|
Dengue fever, unspecifiedDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D2Z |
ABCG2,AURKB
|
Systemic lupus erythematosusDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40.0 |
YES1,CYP1A1
|
Heart failure, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD1Z |
CYP1B1,ABCG2
|
Lyme borreliosisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1C1G |
MET,HBB
|
Gliomas of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.0 |
NOX4,AHR
|
Neuroendocrine carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C34 |
NCT01524094,NCT03164382,NCT00003558,NCT02172976,NCT04325425,NCT03168607,NCT01489566,NCT03837977,NCT00953394,NCT02246127,NCT03387592,NCT03092895,NCT00001569,NCT00022178,NCT02820857,NCT04919226,NCT01858025,NCT05015621
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
CA7,CISD1,POLB,TP53,DPP4,XDH,TOP1,HSD17B2,AURKB,HSD17B10,GMNN,MET,YES1,CYP19A1,ALOX15,NPSR1,TSHR
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
CISD1,ALOX12,TP53,XDH,HSD17B2,AHR,GMNN,CHEK1,NOX4,MET,YES1,ALOX15,CSNK2A3,CA12,CYP1A2,ALOX5,TSHR
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
CHEK1,AURKB,SSTR3,CA12,NOX4,SRC,IGF1R,PMP22,GMNN,HBB,CDK1,CYP19A1
NCT00003994,NCT03017326,NCT00980460,NCT04478292 |
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
ALOX12,SRC,TP53,PMP22,AURKB,HIF1A,GMNN,CDK1,CHEK1,TUBB6,NOX4,SSTR3,CSNK2A3,ALOX5,IGF1R,LMNA
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
CHEK1,AURKB,SSTR3,CA12,NOX4,CDK1,GMNN,CYP19A1,CHEK1,AURKB,CA12,SRC,CDK1,GMNN,CYP19A1,SSTR3
|
Biliary tract cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
MET
NCT01494363,NCT01572324,NCT03778593,NCT04217954,NCT03785873,NCT01127555,NCT03291899,NCT05052099,NCT03524508,NCT03110510,NCT00090025,NCT04722133,NCT04005339 |
Malignant neoplasms of anus or anal canalDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C00 |
NCT02059499,NCT00068744,NCT00324415,NCT00955240,NCT00025090,NCT00316888,NCT00003596,NCT01324141,NCT01621217,NCT00423293,NCT02369939,NCT00003652,NCT02402842
|
Malignant neoplasm of pancreas, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.Z |
NCT04431258,NCT03699319,NCT03586869,NCT03563248,NCT05360732,NCT04324307,NCT00026130,NCT04589234,NCT00262951,NCT04161755,NCT02021422,NCT02827201,NCT00002955,NCT00059826,NCT02128100,NCT05466799,NCT03941093,NCT02506842,NCT01473303,NCT04807972,NCT02351219,NCT01688336,NCT01905150,NCT01827553,NCT02539537,NCT00033735,NCT00002689,NCT03443492,NCT03042780,NCT00786006,NCT00058201,NCT02311439,NCT05047991,NCT02574663,NCT00068575,NCT00960284,NCT00112697,NCT00601627,NCT04228601,NCT00089024,NCT01836432,NCT00609765,NCT01632306,NCT03504423,NCT05251038,NCT03387098,NCT03484299,NCT03329248,NCT01754623,NCT00003029,NCT00045747,NCT03693677,NCT03487016,NCT03336216,NCT00251355,NCT00416507,NCT00417976,NCT02241551,NCT01888978,NCT00004003,NCT00005871,NCT00303758,NCT00436267,NCT05065801,NCT02355119,NCT04672005,NCT00010062,NCT04897854,NCT00003216,NCT01485744,NCT04594772,NCT03883919,NCT00024427,NCT01652976,NCT04084496,NCT00005870,NCT01992705,NCT01488552,NCT04089150,NCT03991962,NCT04390399,NCT03136406,NCT02551991,NCT03167112,NCT03563144,NCT02676349,NCT02717091,NCT02923921,NCT00463840,NCT00323583,NCT02352337,NCT03760614,NCT03899636,NCT02028806,NCT03861702,NCT02672917,NCT02405585,NCT01591733,NCT00660270,NCT01560949,NCT01489865,NCT01063192,NCT01821729,NCT01661088,NCT00602602,NCT00424827,NCT00003049,NCT02581215,NCT00112658,NCT01523457,NCT00003018,NCT05462496,NCT00049348,NCT01867892,NCT02919787,NCT03600623,NCT01454180,NCT01446458,NCT04371224,NCT00275119,NCT04769414,NCT01494506
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
CHEK1,AURKB,CA7,CA12,TSHR,THPO,NPSR1,HTR2B,GMNN,CDK1,CYP2C9,XDH
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
CSNK2A3,TUBB6,CYP1B1,CA12,KDR,MET,DPP4,GMNN,CYP19A1,TSHR,LMNA,RAB9A
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
CHEK1,AURKB,CA7,NOX4,CA12,MET,DPP4,GMNN,CDK1,CYP19A1,SSTR3,HSD17B2
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
TOP1,MET,MTOR,SRC,EGFR,CDK1,CYP19A1,CA12,IGF1R,AXL,KDR
NCT01358877,NCT02846428,NCT01966471,NCT00776724,NCT01593020,NCT01036087,NCT00129922,NCT00002784,NCT00929591,NCT00002498,NCT00152178,NCT00773695,NCT00615602,NCT02897700,NCT04127019,NCT00053911,NCT00010075,NCT00055679,NCT00003680,NCT00036868,NCT00005581,NCT00431080,NCT00309478,NCT00309569,NCT02132949,NCT00629278,NCT00499603,NCT00012311,NCT00002580,NCT00014222,NCT01231802,NCT02365805,NCT00311636,NCT01985841,NCT02995772,NCT00047099,NCT00193011,NCT03387085,NCT00331097,NCT04031703,NCT00124111,NCT00559845,NCT03175666,NCT00003013,NCT00017095,NCT00872625,NCT00433420,NCT00525759,NCT00033683,NCT02393833,NCT00533936,NCT01314833,NCT00001498,NCT01642771,NCT02742051,NCT01216111,NCT02225652,NCT01204437,NCT03554109,NCT02115152,NCT00002870,NCT00950300,NCT00336791,NCT00625898,NCT02980965,NCT00054587,NCT01985724,NCT01855828,NCT00152191,NCT00963729,NCT00688740,NCT00002581,NCT00038402,NCT00129389,NCT00003012,NCT00630032,NCT01222052,NCT00087178,NCT00756470,NCT00002582,NCT00015886,NCT03888677,NCT02450058,NCT02115204,NCT01270373,NCT00002696,NCT00003086,NCT00002579,NCT02897050,NCT02400567,NCT00002755,NCT00301925,NCT00003893,NCT01937507,NCT00003577,NCT00820547,NCT00002542,NCT01031030,NCT02681003 |
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
TOP1,MTOR,FLT3,CDK1,IGF1R,ALOX5,MET,CHEK1,AXL,KDR,EGFR
|
Liver cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12 |
IGF1R,EGFR,KDR,MET,CSNK2A1,MTOR
NCT00238160,NCT00507585,NCT03092895,NCT03164382,NCT00471484 |
Actinic keratosisDisease Category: X.Extension CodesDisease ICD-11 Code: XH36H6 |
NCT02616601,NCT02281682,NCT03037541,NCT05078827,NCT00696488,NCT02019355,NCT04875026,NCT02289768,NCT00377273,NCT01354717,NCT01525329
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
CA7,ALOX12,XDH,AURKB,GMNN,CDK1,CYP2C9,CHEK1,CA12,NPSR1,TSHR
|
Rectum cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B92 |
NCT01650428,NCT01716949,NCT02423226,NCT04838496,NCT00349076,NCT01060007,NCT05412082,NCT00321685,NCT02465593,NCT02270606,NCT03043729,NCT01941641,NCT00942266,NCT00303628,NCT00101894,NCT03161574,NCT03085992,NCT05009069,NCT01211210,NCT00832299,NCT00527111,NCT01871571,NCT00865189,NCT00052559,NCT01376453,NCT05022030,NCT05111860,NCT03000374,NCT05378919,NCT04418895,NCT02704520,NCT04165772,NCT01238965,NCT04130854,NCT00003873,NCT03299660,NCT02942563,NCT03152370,NCT01302613,NCT02280070,NCT05201430,NCT01269229,NCT02887313,NCT01270438,NCT04423965,NCT03671252,NCT01269216,NCT05108428,NCT03428529,NCT04495088,NCT00307736,NCT03921684,NCT03127007,NCT04621370,NCT01197664,NCT03300544,NCT00278694,NCT00611858,NCT01500993,NCT01198548,NCT02217020,NCT01481545,NCT04170530,NCT02340949,NCT02008656,NCT00145769,NCT02941562,NCT00422864,NCT02319304,NCT03391843,NCT03548961,NCT05024097,NCT03781323,NCT04380337,NCT00003799,NCT04009876,NCT05074966,NCT01274962,NCT00499369,NCT04808323,NCT00707889,NCT01347645,NCT04215731,NCT01013805,NCT01111604,NCT02514278,NCT05358704,NCT03443661,NCT00807911,NCT01554059,NCT00235898,NCT02167321,NCT03259035,NCT00070122,NCT01205022,NCT02921256,NCT02688712,NCT00580073,NCT00025337,NCT03879109,NCT03975049,NCT03484221,NCT05253846,NCT00337389,NCT01740648,NCT00006094,NCT02574663,NCT02041481
|
Other specified malignant neoplasms of kidney, except renal pelvisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C90.Y |
TYR,AURKB,MET,ALOX5,CYP2C9,CYP19A1,XDH,TSHR,AURKB,ALOX5
|
ParkinsonismDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A00 |
SRC
|
Diabetes mellitus, type unspecifiedDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A14 |
DPP4
|
Seborrhoeic dermatitisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA81 |
CA12
|
Extraocular muscle disorderDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9C82 |
IGF1R
|
LymphangioleiomyomatosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CB07 |
MTOR
|
Kidney failureDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB60-GB6Z |
TP53
|
MastocytosisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A21 |
FLT3
|
Carcinoid syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B10 |
ALOX5
|
FilariasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F66 |
ALOX5
|
NeuropathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
CYP19A1
|
Multiple structural anomalies syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2F |
IGF1R
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
CYP19A1
|
HydrocephalusDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8D64 |
MTOR
|
Unspecified viral infection of unspecified siteDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D9Z |
FLT3
|
Testicular cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80 |
EGFR
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
DPP4
|
Digestive organ benign neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E92 |
KDR
|
EncephalopathyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8E47 |
XDH
|
Metastatic malignant neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D50-2E09 |
AXL
|
Ureteral cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C92 |
AHR
|
Intracerebral haemorrhageDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B00 |
EGFR
|
Synovial sarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B5A |
SRC
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
MET
|
Epidermal dysplasiasDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EK90 |
SRC
|
Hepatitis virus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E50-1E51 |
EGFR
|
Angina pectorisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40 |
EGFR
|
Pleural mesotheliomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26 |
MTOR
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
XDH
|
Mineral deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B5K |
XDH
|
Bone/articular cartilage neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2F7B |
FLT3
|
OsteosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B51 |
SRC
|
Ovarian dysfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A80 |
TP53
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
HIF1A
|
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
SRC
|
Transplanted organ/tissueDisease Category: 24.Factors influencing health status or contact with health servicesDisease ICD-11 Code: QB63 |
FLT3
|
Attention deficit hyperactivity disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A05 |
HTR2B
|
Skin postprocedural disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EL8Y |
EGFR
|
Arteries/arterioles disorderDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD52 |
MTOR
|
Spinal cord/cranial nerve neoplasmDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A02 |
EGFR
|
Diffuse large B-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
FLT3
|
Inflammatory arthropathyDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA2Z |
FLT3
|
Anal cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C00 |
CHEK1
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
HTR2B
|
Inborn purine/pyrimidine/nucleotide metabolism errorDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C55 |
XDH
|
Hodgkin lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B30 |
CHEK1
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
XDH
|
Irritable bowel syndromeDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD91 |
ABCG2
|
Hypo-thyroidismDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A00 |
TSHR
|
LiposarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B59 |
TP53
|
Colon cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90 |
EGFR
|
Liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB90-DB9Z |
MET
|
EndometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10 |
CYP19A1
|
Sickle-cell disorderDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A51 |
HBB
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
IGF1R
|
Acquired hypermelanosisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED60 |
TYR
|
Acquired hypomelanotic disorderDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED63 |
TYR
|
Psychotic disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A20-6A25 |
HTR2B
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
CSNK2A1
|
LeiomyosarcomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B58 |
SRC
|
Phakomatoses/hamartoneoplastic syndromeDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LD2D |
FLT3
|
Metabolic disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C50-5D2Z |
DPP4
|
ThyrotoxicosisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A02 |
IGF1R
|
Diabetic foot ulcerDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD54 |
EGFR
|
Metastatic biliary tract neoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C14-2C17 |
EGFR
|
ThalassaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A50 |
HBB
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
ALOX5
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO
|
Gastro-oesophageal reflux diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA22 |
NCT02226484
|
Malignant neoplasms of larynx, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C23.Z |
NCT00508664
|
Ependymoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH1511 |
NCT01498783
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Mucinous adenocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH1S75 |
NCT00068692
|
Malignant neoplasms of fallopian tube, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C74.Z |
NCT02419495
|
Malignant neoplasms of corpus uteriDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76 |
NCT00782041
|
Malignant neoplasms of retroperitoneumDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C50 |
NCT00625092
|
Follicular lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A80 |
NCT00455416
|
Macular degenerationDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B75 |
NCT05062486
|
Transitional cell carcinoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH8EH1 |
NCT03197571
|
Deep vein thrombosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD71 |
NCT00849264
|
Melanoma of skin, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C30.Z |
NCT02419495
|
Cystic fibrosisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA25 |
NCT01348204
|
Central nervous system diseaseDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A04-8D87 |
NCT01498783
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT01438320
|
Basal cell carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C32 |
NCT03541252
|
Chalazion, unspecifiedDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9A02.0Z |
NCT02025023
|
Malignant neoplasms of other or unspecified parts of biliary tractDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C17 |
NCT05350943
|
Lichen planusDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA91 |
NCT01375101
|
Squamous cell carcinoma of oropharynxDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B6A.0 |
NCT03323463
|
Squamous intraepithelial neoplasia, high gradeDisease Category: X.Extension CodesDisease ICD-11 Code: XH3EA2 |
NCT02059499
|
Myeloproliferative neoplasm, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5HH7 |
NCT00003331
|
Malignant neoplasms of nasal cavityDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C20 |
NCT00117572
|
Low grade squamous intraepithelial lesion of cervix uteriDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA15.7 |
NCT00000758
|
skin carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C31.0-2E67.40 |
NCT02218164
|
Polyneuropathy, unspecifiedDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C0Z |
NCT02590367
|
Signet ring cell carcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH4546 |
NCT00217737
|
Malignant lymphoma, NOSDisease Category: X.Extension CodesDisease ICD-11 Code: XH5FJ5 |
NCT00002524
|
Malignant neoplasms of other or unspecified parts of mouthDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B66 |
NCT05456022
|
Breast in situ carcinomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2E65 |
NCT02419495
|
Carcinomas of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.0 |
NCT02419495
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT05276895
|
Congenital aplastic anaemiaDisease Category: 03.Diseases of the blood or blood-forming organsDisease ICD-11 Code: 3A70.0 |
NCT01720147
|
Non-alcoholic steatohepatitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92.1 |
HBB
|
Hypertrophic cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.1 |
HBB
|
Inflammatory bowel diseases, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD7Z |
NOX4
|
Zika virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D48 |
AXL
|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
CA7
|
Non-alcoholic fatty liver diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB92 |
HBB
|
Myotonic dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C71.0 |
CYP1A1
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
ABCG2
|
Pneumonia due to PseudomonasaeruginosaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.05 |
DPP4
|
Systemic sclerosisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A42 |
NOX4
|
Chronic rhinosinusitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA0A |
CYP1A1
|
Dilated cardiomyopathyDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC43.0 |
ABCG2
|